US20020173851A1 - Intervertebral disc treatment devices and methods - Google Patents
Intervertebral disc treatment devices and methods Download PDFInfo
- Publication number
- US20020173851A1 US20020173851A1 US10/165,347 US16534702A US2002173851A1 US 20020173851 A1 US20020173851 A1 US 20020173851A1 US 16534702 A US16534702 A US 16534702A US 2002173851 A1 US2002173851 A1 US 2002173851A1
- Authority
- US
- United States
- Prior art keywords
- disc
- growth factor
- tissue growth
- bmp
- members
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/441—Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4603—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2/4611—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof of spinal prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2/30965—Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30075—Properties of materials and coating materials swellable, e.g. when wetted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
- A61F2002/3023—Three-dimensional shapes cylindrical wedge-shaped cylinders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/4435—Support means or repair of the natural disc wall, i.e. annulus, e.g. using plates, membranes or meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/444—Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2002/4495—Joints for the spine, e.g. vertebrae, spinal discs having a fabric structure, e.g. made from wires or fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4603—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2002/4625—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof with relative movement between parts of the instrument during use
- A61F2002/4627—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof with relative movement between parts of the instrument during use with linear motion along or rotating motion about the instrument axis or the implantation direction, e.g. telescopic, along a guiding rod, screwing inside the instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0061—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof swellable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
- A61F2310/00377—Fibrin
Definitions
- the present invention relates generally to devices and methods for restoring function to the spine. Specifically, the invention relates to devices and methods for treating a damaged intervertebral disc while retaining the annulus fibrosis of the disc and, advantageously, stimulating tissue formation to restore function to the original disc structure.
- Intervertebral discs located between the endplates of adjacent vertebrae, stabilize the spine, distribute forces between vertebrae, and cushion vertebral bodies.
- An intervertebral disc includes the annulus fibrosus, a structure that surrounds and confines an inner component, the nucleus pulposus.
- the annulus fibrosis is composed of a ring of collagen fibers and fibrocartilage embedded in a generally amorphous base substance.
- the nucleus pulposus is comprised of a mucoid material containing mainly glycoproteins and some collagen. In a healthy, undamaged spine, the annulus fibrosus prevents the nucleus pulposus from protruding outside the disc space and also resists torsional and bending forces applied to the disc.
- Intervertebral discs may be displaced or damaged due to disease or aging. Disruption of the annulus fibrosus can allow the nucleus pulposus to protrude into the vertebral canal or intervertebral foramen, a condition known as a herniated or slipped disc. A rupture in the annulus fibrosis can allow the escape of nucleus pulposus components. The extruded nucleus pulposus may press on a spinal nerve, which may result in nerve damage, pain, numbness, muscle weakness and paralysis. Furthermore, as a disc dehydrates and hardens due to age or disease, the disc space height will be reduced, leading to instability of the spine, decreased mobility and pain. Moreover, excessive movement of the spinal segments caused by the disc space height reduction could weaken the annulus fibrosus and, in certain cases, tear it.
- the present invention relates to methods and devices for repairing an intervertebral disc which include promoting synthesis of tissue components, such as nucleus pulposus and/or annulus fibrosus components, of the disc.
- the present invention provides a device which can be used to promote the synthesis of disc components in vivo to treat intervertebral discs.
- a device for treating an intervertebral disc of a vertebrate while retaining an intact annulus fibrosis the device including a compressible fibrous body configurable to a compressed state for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis.
- the body is also configurable to an expanded state to reside within the disc cavity and have a dimension greater than the opening so as to resist expulsion from the opening.
- the body incorporates an effective amount of an active agent, such as a tissue growth factor, or cells (e.g. stem, nucleus pulposus, annulus fibrosis, or fibroblast cells), such cells optionally genetically modified to express effective amounts of a tissue growth factor, to stimulate tissue growth in the disc structure.
- an active agent such as a tissue growth factor, or cells (e.g. stem, nucleus pulposus, annulus fibrosis, or fibroblast cells), such cells optionally genetically modified to express effective amounts of a tissue growth factor, to stimulate tissue growth in the disc structure.
- an intervertebral disc treatment device including a fibrous body sized for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis.
- the body is formed of fibers having coated thereon a solid carrier matrix incorporating a substance for promoting tissue growth.
- the body of the device may be partially or completely bioresorbable.
- the body may be sized and configured to provide temporary or permanent prosthetic function, by being dimensioned to participate in the distribution of compressive loads between adjacent vertebral bodies.
- the body may be adapted to physically maintain a space in the disc as new tissue is generated, and provide a substrate for tissue ingrowth which locks the implant in place and reinforces regenerated tissues to help maintain disc space height.
- the body may be non-prosthetic, while delivering a substance for promoting tissue growth in the disc structure.
- the device can be dimensioned, or can be formed of a material having compressive properties, such that it does not participate in the distribution of loads between the adjacent vertebral bodies. Nonetheless, such a non-prosthetic body may deliver the tissue growth substance so as to enhance the function or integrity of the disc structure.
- Another feature of the invention provides an intervertebral disc repair apparatus that has a disc treatment device as described above in combination with a delivery apparatus.
- the delivery apparatus is adapted to retain and selectively release the treatment device into the disc cavity, and may for example include a member having a proximal end, a distal end and a lumen extending longitudinally therethrough.
- the disc repair device is disposed within the lumen of the apparatus.
- the delivery apparatus is adapted to translate the disc repair device distally through the lumen, through an opening in the annulus fibrosis, and into the disc cavity.
- Yet other features of the invention include methods for treating an intervertebral disc, which involve introducing a disc treatment device as described above into the disc cavity of a damaged disc.
- methods for treating a disc having an annulus fibrosis having an opening therein which methods include providing a body configured for passage through the opening and for blocking effluence from the opening once positioned within the disc cavity. The body is passed through the opening and into the disc cavity, so as to block effluence from the opening.
- a tissue growth composition is also provided within the disc cavity, either as a component of the body or separately.
- FIG. 1 is a perspective view of a disc treatment device of the present invention.
- FIG. 2 is an enlarged, cross-sectional view of the device of FIG. 1 taken along a vertical plane through line 2 - 2 and viewed in the direction of the arrows.
- FIG. 3 is a perspective view of a further disc treatment device of the present invention having an annular ring shape.
- FIG. 4 is a perspective view of a further disc treatment device of the present invention.
- FIG. 5 is a side cross-sectional view illustrating the disc repair device shown in FIG. 1 positioned within an intervertebral disc.
- FIG. 6 is a superior view of the disc treatment device of FIG. 1 positioned in the disc cavity of an intervertebral disc.
- FIG. 7 is a superior view of the disc treatment device of FIG. 3 positioned in the disc cavity of an intervertebral disc.
- FIG. 8 is a superior view of the disc treatment device of FIG. 4 positioned in the disc cavity of an intervertebral disc.
- FIG. 9 is a superior view illustrating two disc treatment devices positioned in the disc cavity of an intervertebral disc, and wherein an opening in the annulus fibrosis is sealed with a sealant composition.
- FIG. 10 is a superior view illustrating first and second disc treatment devices positioned within the disc cavity of an intervertebral disc, wherein one functions to seal a rupture in the annulus fibrosis.
- FIG. 11 is a side cross-sectional view of a disc treatment apparatus, showing the disc treatment device of FIG. 3 in a compressed conformation in the lumen of a delivery apparatus.
- FIG. 12 is a side cross-sectional view of a disc treatment apparatus, showing the disc treatment device of FIG. 4 in a compressed conformation in the lumen of a delivery apparatus.
- FIGS. 13 and 14 are superior views illustrating the use of the disc treatment apparatus of FIG. 11 to release the disc treatment device of FIG. 3 into a disc cavity.
- FIG. 15 is a perspective view of another disc treatment device of the invention.
- FIGS. 16 - 18 illustrate elongate implants of the invention and apparatuses and methods for their introduction into the disc cavity.
- FIGS. 19 - 21 illustrate elongate implants of the invention and additional apparatuses and methods for their introduction into the disc cavity.
- the present invention provides intervertebral disc treatment devices, apparatuses and methods.
- Preferred devices include a fibrous body configurable to smaller (compressed) and larger (relaxed) dimensional states. In the small configuration the body is adapted for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis. In the larger configuration the body is dimensioned sufficiently to resist expulsion from the annulus opening when positioned within the disc cavity. The body incorporates an effective amount of a substance which promotes tissue formation in the disc structure.
- inventive apparatuses are provided which include such fibrous bodies in combination with a delivery apparatus adapted to retain and selectively release the bodies into the disc cavities, and inventive methods are also provided can be performed using the devices and apparatuses of the invention.
- a preferred intervertebral disc treatment device 11 that includes an outer surface 12 , and opposing ends 13 .
- Device 11 is elongate in shape, having a generally cylindrical configuration with a circular cross-section.
- Device 11 has a length L and a cross-sectional dimension adapted for insertion into the disc cavity of a damaged disk.
- length L will be about equal to or less than a horizontal cross-sectional dimension of the disc cavity of a human disc (e.g. the anterior-posterior width and/or the lateral width of the disc cavity), typically in the range of about 1.5 cm to about 3.5 cm.
- device 11 will be of a size and composition so as to avoid the exertion of substantial lateral pressure upon the annulus fibrosis by the device, which may cause or facilitate the development of a rupture in the annulus fibrosis.
- Device 11 will have or be compressible radially to have a greatest cross-sectional dimension which renders device 11 suited for insertion into an opening in a disc annulus, such greatest cross-sectional dimension typically being in the range of about 0.3 cm to about 2.0 cm.
- Device 11 may, for instance, have a body comprised of a woven or nonwoven fibrous material, including but not limited to a fibrous mesh.
- the body of device 11 is also preferably swellable in the presence of aqueous fluids, for example swelling upon absorbing aqueous fluids into pores created between fibers in a fibrous body, and/or upon hydration of the fibers themselves.
- device 11 may be formed as a roll of a sheet material, for instance a fibrous mesh, to provide a multi-layered device.
- the device may be constructed to prevent, or alternatively to allow, for unrolling or unfolding of the layers after insertion into the disc cavity.
- layers may be permanently affixed to one another such as by bonding, crosslinking or stitching, to prevent unfolding.
- layers may be free of permanent affixation to one another (e.g.
- Such unfolding may, for example, participate in configuring the device to resist expulsion from an annulus fibrosis opening, and/or to occupy a modified volume within the disc cavity for supporting tissue ingrowth.
- the device may assume a variety of other configurations including spherical, rectangular, conical, ring, and other shapes. It is preferred that the device be shaped so that it can facilitate blocking an opening in the annulus fibrosus of a damaged intervertebral disc when positioned in the disc cavity.
- the device may have a first end having a cross-sectional dimension smaller than another cross-sectional dimension along the device, for example having an increasing cross-sectional dimension along the device length such as occurs in a generally conical device.
- such a disc repair device 21 having a generally conical shape with a larger end 22 and an outer surface 23 that tapers towards a smaller opposing end 24 .
- the device may be collapsible in upon itself to have a smaller overall cross-sectional dimension in a direction in which it is to be inserted, for example in the case of an annular ring.
- Shown in FIG. 4 is such a disc treatment device 31 , having the shape of an annular ring.
- Device 31 preferably has an outer diameter, when expanded, approximating the horizontal width of the disc cavity, and can be collapsed upon itself to adopt a smaller overall cross-sectional dimension for insertion through an opening in the annulus fibrosis.
- FIG. 5 shown is a side cross-sectional view of a intervertebral disc having positioned therein disc treatment device 11 of FIG. 1.
- an intervertebral disc 41 includes the annulus fibrosus 42 formed from multiple layers of type II collagenous tissue, bounding an internal disc cavity 43 .
- Disc treatment device 11 is sized and configured to be contained within the disc cavity and in the illustrated embodiment has a vertical dimension to contact the upper and lower surfaces of the disc cavity formed by end plates of adjacent vertebrae.
- device 11 has a horizontal dimension substantially spanning the horizontal width of the disc cavity 43 .
- Device 11 also abuts the inner surface of the annulus fibrosus 42 so as to facilitate blockage of effluence from disc cavity 43 via opening 44 in annulus fibrosus 42 .
- Opening 44 in annulus fibrosis 42 often occurs posterolaterally, where the annulus fibrosis is no longer supported by the posterior longitudinal ligament.
- device 11 or other disc treatment devices of the invention can be inserted via a posterolateral approach, although other approaches may be used which correspond to the location of the rupture in the disc to be treated, or which involve insertion of the device through a conservative, alternate opening created in a spaced location from the rupture.
- FIGS. 6, 7, and 8 shown are superior views of disc treatment devices 11 , 21 , and 31 , respectively, positioned within the disc cavity of a ruptured disc.
- the disc treatment devices of the invention may be formed from a wide variety of natural and/or synthetic materials, preferably natural and/or synthetic polymers.
- Natural polymers include, for example, collagen, elastin, and cellulose and may be obtained from natural sources by methods known to the skilled artisan, synthesized by methods known to those skilled in the art, or may be obtained commercially.
- Synthetic polymers which may be used in the present invention include, for example, polyamides, polyesters (e.g., Dacron), polyethylene, polyacrylonitrile, polyurethanes, polypropylenes or mixtures thereof. Combinations of natural and synthetic materials may also form an appropriate fibrous body for use in the present invention.
- the preferred devices of the invention advantageously incorporate a tissue growth factor.
- the device includes a liquid or solid carrier containing the tissue growth factor.
- a solid or liquid carrier containing the growth factor may be used to coat the exterior of the device, and/or may be incorporated within interstitial spaces (e.g. pores) occurring internally of the device.
- a solid carrier matrix containing the growth factor may be used to coat individual fibers from which the body of the disc treatment device is formed.
- the growth factor is generally suited to promote the formation of tissues, especially of the type(s) naturally occurring as internal or external components of the disc.
- the growth factor may promote the growth or viability of tissue or cell types occurring in the nucleus pulposus such as nucleus pulposus cells and chondrocytes, as well as space filling cells such as fibroblasts and connective tissue cells such as ligament and tendon cells.
- the growth factor may promote the growth or viability of tissue types occurring in the annulus fibrosus, as well as space filling cells such as fibroblasts and connective tissue cells such as ligament and tendon cells.
- Such growth factors include Transforming Growth Factor-beta (TGF-B) and members of the TGF-B superfamily, Fibroblast Growth Factor (FGF) and members of the FGF family, Platelet Derived Growth Factor (PDGF) and members of the PDGF family, members of the hedgehog family of proteins, interleukins, Insulin-like Growth Factor (IGF) and members of the IGF family, colony-stimulating factor (CSF) and members of the CSF family, Growth Differentiation Factors (GDFs), Cartilage Derived Growth Factors (CDGFs), Cartilage Derived Morphogenic Proteins (CDMPs), Bone Morphogenetic Proteins (BMPs), and mixtures thereof. BMPs are preferred.
- TGF-B Transforming Growth Factor-beta
- FGF Fibroblast Growth Factor
- PDGF Platelet Derived Growth Factor
- GDFs Growth Differentiation Factors
- CDGFs Cartilage Derived Growth Factors
- BMPs A wide variety of BMPs have been identified and may be used in the present invention.
- Human BMPs especially recombinant human BMPs, are preferred, including for instance BMPs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 and 18.
- a variety of such BMPs have proven effective for forming soft connective tissues such as cartilage (e.g. BMP-2 and BMP-4) or ligament and tendon (e.g. BMP-12 and BMP-13), and these and other similarly functional proteins are used with preference in the instant invention.
- BMPs are available from Genetics Institute, Inc., Cambridge, Mass. and may also be prepared by one skilled in the art as described in U.S. Pat. No.
- BMPs are contemplated whether obtained as above or isolated from bone. Methods for isolating BMP from bone are described in U.S. Pat. No. 4,294,753 to Urist and in Urist et al., PNAS 371, 1984. Most preferably, the BMP or other growth factor will be non-osteoinductive or at the least insufficiently osteoinductive to cause a bony fusion of the vertebrae above and below the disc under treatment.
- BMP-12 and/or BMP-13 will be employed in an effective amount to stimulate growth of ligament and/or tendon connective tissue within the disc cavity, for instance as may be evidenced by increased synthesis of proteoglycans and collagens.
- Recombinant human BMP-13 is most preferred in this regard.
- a wide variety of materials may be utilized as solid carriers. Examples include natural polymers such as collagen, gelatin, elastin, cellulose, and the like.
- the carrier is collagen.
- types of collagen may be used, including type I (found primarily in skin, tendon and bone), type II (found in cartilage), type III (found primarily in skin), fibrillar and non-fibrillar collagen.
- the collagen may be isolated from skin, bone, tendon, or cartilage by methods known to the skilled artisan and may be purified by methods known in the art. Alternately, the collagen may be purchased commercially. Moreover, atelopeptidic or telopeptidic collagen may be used.
- the tissue growth factor may be applied to the device as described above or may be introduced into the disc space or cavity separately (e.g. by injection), or by recombinant DNA methods.
- a nucleic acid sequence such as a deoxyribonucleic acid sequence, encoding the particular growth factor, or an active fragment thereof, may be introduced into an appropriate vector.
- the vector may be a wide variety of vectors typically used in gene transfer protocols, including, for example, retroviral vectors or adenovirus vectors.
- the vector construct may be synthesized by methods known to the skilled artisan.
- the nucleic acid sequence may be under the control of, and operably linked to, a promoter or other regulatory sequence known in the art.
- the promoter is preferably one which may be activated in the target cell by regulatory elements present in the target cell.
- the disc repair device advantageously includes a therapeutically effective amount of the tissue growth factor. What constitutes an effective amount will vary depending on factors known to the skilled artisan, such as the specific growth factor used and the extent and type of the damage to the intervertebral disc. However, the disc repair device will typically contain about 2 mg to about 20 mg of the growth factor. When BMP-9 is used, for example, amounts applied may include about 8 mg to about 12 mg.
- an intervertebral disc treatment apparatus that includes a disc repair device as described above in combination with a delivery apparatus.
- apparatus 61 is shown that includes the generally conical disc repair device 21 of FIG. 3, in compressed configuration within the apparatus.
- the disc treatment apparatus 61 includes tubular or barrel member 62 having proximal end, a distal end, and a lumen 63 extending longitudinally therethrough.
- Member 62 may be similar to the barrel of a syringe as known in the art.
- Lumen 63 is configured for housing the disc repair device.
- Member 62 may be constructed of a wide variety of materials, including polytetrafluoroethylene (Teflon), polyethylene, polyurethane, nylon, glass, or combinations thereof.
- Disc repair delivery apparatus 61 further includes a translation member 64 at the proximal end of tubular member 62 or forcing the disc repair device 21 distally through lumen 63 , through an opening in the annulus fibrosus of a damaged disc, and into the disc cavity of the disc.
- Translation member 64 may be an elongated member sized to at least partially fit within lumen 63 of member 62 and which is capable of pushing the disc repair device distally along lumen 63 .
- member 64 may be a plunger including a handle 67 , an elongate rod 66 , and an internal member 65 substantially spanning the lumen 63 of tubular member 62 , as seen in FIG. 8.
- translation member 64 may be replaced by other means for translating device 21 along lumen 63 .
- fluid (e.g. liquid) driven mechanisms may be used.
- the disc repair device such as disc repair device 21 , is preferably placed in a collapsed or compressed conformation as shown in FIG. 11, advantageously by manual force, prior to or upon positioning the device 21 in lumen 63 shown in FIG. 12 is a similar disc treatment apparatus 71 except including therein device 31 of FIG. 4 in compressed configuration, instead of device 21 of FIG. 3.
- a method of treating an intervertebral disc includes providing a disc treatment device as described above, such as a fibrous body sized for introduction into an opening of an annulus fibrosus of a damaged intervertebral disc, and inserting the fibrous body into and through the opening, and blocking effluence from the opening.
- a disc repair delivery apparatus 61 or 71 as described above may be used.
- lumen 63 of tubular member 62 is aligned with the opening in the annulus fibrosus of an intervertebral disc so that the disc repair device may be pushed distally along lumen 63 , through the opening in the annulus and into the disc cavity.
- the disc repair device will then adopt an expanded conformation as seen in FIG. 14.
- FIG. 15 shown is an alternative disc treatment device 70 , having a generally bulbous end 71 and a generally cylindrical end 72 .
- Bulbous end 71 has a greatest cross-sectional diameter greater than that of cylindrical end 72 .
- device 70 can be compressed and loaded into a cylindrical delivery apparatus, and delivered through a hole in the annulus and into the disc cavity, preferably first introducing bulbous end 71 . Device 70 can then expand within the disc cavity.
- FIGS. 16 - 18 illustrated is one mode of introducing an elongate implant body through an opening 75 in an annulus 76 (e.g. in the location of a rupture opening), and into the disc cavity 77 .
- An elongate, cylindrical implant 78 is provided (e.g. a Dacron mesh cylinder) having an internal suture 79 or other similar structure running therethrough and tied off or otherwise connected at an end 80 of implant 78 .
- the other end of suture 79 is tied to a curved needle 81 .
- implant 78 can be loaded within a rigid tube 82 , with needle 81 and an exposed length of suture 79 extending therefrom.
- Needle 81 can be passed through opening 75 in annulus 76 and into the disc cavity 77 , and then back through the annulus 76 at a spaced location from opening 75 , for example at an opposite, posterolateral position which can be surgically accessed separately. Suture 79 can then be pulled to in turn pull implant 78 into the disc cavity 77 . Suture 79 can then be closely cut or broken so as to partially retract into the annulus.
- FIG. 19 illustrates another apparatus and method for delivering an implant 85 , such as a cylindrical Dacron mesh implant, into a disc cavity.
- Implant 85 is loaded within a rigid cannula tube 86 , which in turn is passed through the opening in the annulus.
- implant 85 can be loaded in a dry or wet state, preferably a dry, compressed state.
- Implant 85 is then advanced through the tube 86 using push or plunger rod 87 , and into the disc cavity.
- a dry implant 85 will hydrate, and preferably swell, in situ in the disc cavity.
- the internal surface of the tube 86 and the exterior surface of the rod 87 can be provided with respective cooperating members, such as threads, to assist in controllably advancing implant 85 through the tube 86 .
- the inner surface of tube 86 may bear threads, while the external surface of rod 87 bears corresponding threads. In this fashion, rotation of rod 87 in relation to tube 86 will advance rod 87 through tube 86 , thereby pushing implant 85 through tube 86 .
- the implant 85 and/or the internal surface of tube 86 may be coated with a suitable, biocompatible lubricant to reduce the friction between the implant 85 and the tube 86 during the advancement operation.
- a rigid cannula tube 90 defines an opening such as a slot 91 in a sidewall thereof.
- a plurality of openings may also be provided.
- a friction member 92 is mounted over tube 90 and includes an engaging portion 93 extending into slot 91 so as to provide frictional contact with an implant 94 inside tube 90 .
- implant 94 can be advanced through tube 90 by corresponding advancement of the friction member 92 while its engaging portion 93 frictionally engages implant 94 through slot 91 .
- the frictional engagement of the implant 94 can optionally be facilitated by the presence of teeth 95 (e.g.
- engaging portion 93 with implant 94 may be releasable, for example by constructing a deflectable friction member 92 which in a relaxed state disengages engaging portion 93 from the implant, but in a compressed state (e.g. by manually squeezing) engages engaging portion 93 with the implant 94 , or vice versa.
- a tissue growth factor may be provided on the body of or within the device, separately within the disc space of the intervertebral disc, or both. When included separately in the disc space, the tissue growth factor may be provided within the disc space either before or after the disc repair device is positioned. Injection of an aqueous fluid containing the tissue growth factor into the disc repair device may also facilitate expansion of a hydratable, swellable disc repair device immediately after implantation.
- the disc repair device may be adapted and dimensional such that when in its expanded or swollen conformation, the device is of a sufficiently large dimension to contact the overlying and underlying endplates, preferably under compression, so as to secure the device in place in the disc cavity and desirably dissipate compressive loads from the spine.
- All or a portion of the nucleus pulposus of a damaged intervertebral disc may be removed prior to inserting the device. Moreover, the method may also be followed for preventing escape of the nucleus pulposus from a damaged intervertebral disc, as the disc repair devices of the present invention may act as a plug.
- a single disc repair device can have its longitudinal axis positioned perpendicular to longitudinal axis of the vertebral column, or two or more devices can be positioned in this manner (e.g. two devices used in a bilateral configuration).
- Disc treatment devices may be inserted through pre-existing (e.g. rupture) opening in the annulus fibrosus or they may be inserted through a cut or incised opening.
- the one or more devices provided to the disc cavity will substantially fill the existing void in the cavity, and may also have a sufficient vertical dimension to contact the upper and lower surfaces within the cavity, for instance so as to be effective to absorb compressive loads of the spine.
- Delivery apparatuses in accordance with the invention may also be adapted for non- or minimally-invasive delivery of the intervertebral disc treatment device.
- an apparatus can include a cannulated device of sufficient length to extend to the disc cavity from an exterior operating position, and the disc treatment device can be advanced (e.g. in compressed or collapsed form) through and out the distal end of the cannula and into the disc cavity.
- the disc treatment device can be advanced (e.g. in compressed or collapsed form) through and out the distal end of the cannula and into the disc cavity.
- a procedure may immediately follow a known discectomy protocol, including for instance microdiscectomies, endoscopic discectomies, and laparoscopic discectomies.
- the delivery of the disc treatment device may be conducted under endoscopic or other similar visualization techniques.
Abstract
Description
- The present invention relates generally to devices and methods for restoring function to the spine. Specifically, the invention relates to devices and methods for treating a damaged intervertebral disc while retaining the annulus fibrosis of the disc and, advantageously, stimulating tissue formation to restore function to the original disc structure.
- Back pain affects millions of people and is a common cause of disability for the middle-aged working population. A frequent cause of back pain is rupture or degeneration of intervertebral discs. Intervertebral discs, located between the endplates of adjacent vertebrae, stabilize the spine, distribute forces between vertebrae, and cushion vertebral bodies. An intervertebral disc includes the annulus fibrosus, a structure that surrounds and confines an inner component, the nucleus pulposus. The annulus fibrosis is composed of a ring of collagen fibers and fibrocartilage embedded in a generally amorphous base substance. The nucleus pulposus is comprised of a mucoid material containing mainly glycoproteins and some collagen. In a healthy, undamaged spine, the annulus fibrosus prevents the nucleus pulposus from protruding outside the disc space and also resists torsional and bending forces applied to the disc.
- Intervertebral discs may be displaced or damaged due to disease or aging. Disruption of the annulus fibrosus can allow the nucleus pulposus to protrude into the vertebral canal or intervertebral foramen, a condition known as a herniated or slipped disc. A rupture in the annulus fibrosis can allow the escape of nucleus pulposus components. The extruded nucleus pulposus may press on a spinal nerve, which may result in nerve damage, pain, numbness, muscle weakness and paralysis. Furthermore, as a disc dehydrates and hardens due to age or disease, the disc space height will be reduced, leading to instability of the spine, decreased mobility and pain. Moreover, excessive movement of the spinal segments caused by the disc space height reduction could weaken the annulus fibrosus and, in certain cases, tear it.
- Common methods of providing relief for damaged intervertebral discs include surgical removal of all or a portion of the intervertebral disc, followed by fusion of the adjacent vertebrae. Although fusion can eliminate the above symptoms, the restricted motion of the fused segment increases the range of motion required of the adjoining intervertebral discs and could enhance their degeneration.
- Attempts at overcoming the problems with fusion include replacing the entire intervertebral disc with a mechanical, articulating intervertebral disc spacer. Many of these devices utilize multicomponent polymeric and metallic materials in an attempt to simulate the normal, healthy intervertebral disc motion. Such materials may disintegrate in the body and break down under repeated stressing over prolonged periods. Other attempts at overcoming the problems with replacing the entire intervertebral disc have included replacing the nucleus pulposus with elastomeric materials such as hydrogels.
- The present invention relates to methods and devices for repairing an intervertebral disc which include promoting synthesis of tissue components, such as nucleus pulposus and/or annulus fibrosus components, of the disc. In one aspect, the present invention provides a device which can be used to promote the synthesis of disc components in vivo to treat intervertebral discs. In particular, provided is a device for treating an intervertebral disc of a vertebrate while retaining an intact annulus fibrosis, the device including a compressible fibrous body configurable to a compressed state for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis. The body is also configurable to an expanded state to reside within the disc cavity and have a dimension greater than the opening so as to resist expulsion from the opening. The body incorporates an effective amount of an active agent, such as a tissue growth factor, or cells (e.g. stem, nucleus pulposus, annulus fibrosis, or fibroblast cells), such cells optionally genetically modified to express effective amounts of a tissue growth factor, to stimulate tissue growth in the disc structure.
- Another aspect of the invention provides an intervertebral disc treatment device including a fibrous body sized for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis. The body is formed of fibers having coated thereon a solid carrier matrix incorporating a substance for promoting tissue growth.
- In the above-discussed aspects of the invention, the body of the device may be partially or completely bioresorbable. In addition, the body may be sized and configured to provide temporary or permanent prosthetic function, by being dimensioned to participate in the distribution of compressive loads between adjacent vertebral bodies. For example, the body may be adapted to physically maintain a space in the disc as new tissue is generated, and provide a substrate for tissue ingrowth which locks the implant in place and reinforces regenerated tissues to help maintain disc space height. In another inventive aspect, the body may be non-prosthetic, while delivering a substance for promoting tissue growth in the disc structure. In such non-prosthetic applications, the device can be dimensioned, or can be formed of a material having compressive properties, such that it does not participate in the distribution of loads between the adjacent vertebral bodies. Nonetheless, such a non-prosthetic body may deliver the tissue growth substance so as to enhance the function or integrity of the disc structure.
- Another feature of the invention provides an intervertebral disc repair apparatus that has a disc treatment device as described above in combination with a delivery apparatus. The delivery apparatus is adapted to retain and selectively release the treatment device into the disc cavity, and may for example include a member having a proximal end, a distal end and a lumen extending longitudinally therethrough. The disc repair device is disposed within the lumen of the apparatus. The delivery apparatus is adapted to translate the disc repair device distally through the lumen, through an opening in the annulus fibrosis, and into the disc cavity.
- Yet other features of the invention include methods for treating an intervertebral disc, which involve introducing a disc treatment device as described above into the disc cavity of a damaged disc.
- In additional embodiments of the invention, methods for treating a disc having an annulus fibrosis having an opening therein, which methods include providing a body configured for passage through the opening and for blocking effluence from the opening once positioned within the disc cavity. The body is passed through the opening and into the disc cavity, so as to block effluence from the opening. A tissue growth composition is also provided within the disc cavity, either as a component of the body or separately.
- It is an object of the invention to provide devices and methods that may be used to provide therapy to a damaged disc by promoting in vivo synthesis of components within the disc structure.
- It is a further object of the invention to provide methods and devices for preventing effluence from a damaged intervertebral disc.
- These and other objects and advantages of the present invention will be apparent from the descriptions herein.
- FIG. 1 is a perspective view of a disc treatment device of the present invention.
- FIG. 2 is an enlarged, cross-sectional view of the device of FIG. 1 taken along a vertical plane through line2-2 and viewed in the direction of the arrows.
- FIG. 3 is a perspective view of a further disc treatment device of the present invention having an annular ring shape.
- FIG. 4 is a perspective view of a further disc treatment device of the present invention.
- FIG. 5 is a side cross-sectional view illustrating the disc repair device shown in FIG. 1 positioned within an intervertebral disc.
- FIG. 6 is a superior view of the disc treatment device of FIG. 1 positioned in the disc cavity of an intervertebral disc.
- FIG. 7 is a superior view of the disc treatment device of FIG. 3 positioned in the disc cavity of an intervertebral disc.
- FIG. 8 is a superior view of the disc treatment device of FIG. 4 positioned in the disc cavity of an intervertebral disc.
- FIG. 9 is a superior view illustrating two disc treatment devices positioned in the disc cavity of an intervertebral disc, and wherein an opening in the annulus fibrosis is sealed with a sealant composition.
- FIG. 10 is a superior view illustrating first and second disc treatment devices positioned within the disc cavity of an intervertebral disc, wherein one functions to seal a rupture in the annulus fibrosis.
- FIG. 11 is a side cross-sectional view of a disc treatment apparatus, showing the disc treatment device of FIG. 3 in a compressed conformation in the lumen of a delivery apparatus.
- FIG. 12 is a side cross-sectional view of a disc treatment apparatus, showing the disc treatment device of FIG. 4 in a compressed conformation in the lumen of a delivery apparatus.
- FIGS. 13 and 14 are superior views illustrating the use of the disc treatment apparatus of FIG. 11 to release the disc treatment device of FIG. 3 into a disc cavity.
- FIG. 15 is a perspective view of another disc treatment device of the invention.
- FIGS.16-18 illustrate elongate implants of the invention and apparatuses and methods for their introduction into the disc cavity.
- FIGS.19-21 illustrate elongate implants of the invention and additional apparatuses and methods for their introduction into the disc cavity.
- For the purposes of promoting an understanding of the principles of the invention, reference will now be made to preferred embodiments thereof and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications of the invention, and such further applications of the principles of the invention as illustrated herein, being contemplated as would normally occur to one skilled in the art to which the invention relates.
- The present invention provides intervertebral disc treatment devices, apparatuses and methods. Preferred devices include a fibrous body configurable to smaller (compressed) and larger (relaxed) dimensional states. In the small configuration the body is adapted for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis. In the larger configuration the body is dimensioned sufficiently to resist expulsion from the annulus opening when positioned within the disc cavity. The body incorporates an effective amount of a substance which promotes tissue formation in the disc structure. Inventive apparatuses are provided which include such fibrous bodies in combination with a delivery apparatus adapted to retain and selectively release the bodies into the disc cavities, and inventive methods are also provided can be performed using the devices and apparatuses of the invention.
- Referring now to FIG. 1, a preferred intervertebral
disc treatment device 11 is illustrated that includes anouter surface 12, and opposing ends 13.Device 11 is elongate in shape, having a generally cylindrical configuration with a circular cross-section.Device 11 has a length L and a cross-sectional dimension adapted for insertion into the disc cavity of a damaged disk. In preferred devices, length L, will be about equal to or less than a horizontal cross-sectional dimension of the disc cavity of a human disc (e.g. the anterior-posterior width and/or the lateral width of the disc cavity), typically in the range of about 1.5 cm to about 3.5 cm. Preferably also,device 11 will be of a size and composition so as to avoid the exertion of substantial lateral pressure upon the annulus fibrosis by the device, which may cause or facilitate the development of a rupture in the annulus fibrosis.Device 11 will have or be compressible radially to have a greatest cross-sectional dimension which rendersdevice 11 suited for insertion into an opening in a disc annulus, such greatest cross-sectional dimension typically being in the range of about 0.3 cm to about 2.0 cm.Device 11 may, for instance, have a body comprised of a woven or nonwoven fibrous material, including but not limited to a fibrous mesh. The body ofdevice 11 is also preferably swellable in the presence of aqueous fluids, for example swelling upon absorbing aqueous fluids into pores created between fibers in a fibrous body, and/or upon hydration of the fibers themselves. - Referring now to FIG. 2, shown is an enlarged, cross-sectional view taken in a vertical plane along line2-2 of FIG. 1 and viewed in the direction of the arrows. As illustrated,
device 11 may be formed as a roll of a sheet material, for instance a fibrous mesh, to provide a multi-layered device. Using such a multi-layered configuration, the device may be constructed to prevent, or alternatively to allow, for unrolling or unfolding of the layers after insertion into the disc cavity. For instance, layers may be permanently affixed to one another such as by bonding, crosslinking or stitching, to prevent unfolding. On the other hand, layers may be free of permanent affixation to one another (e.g. non-affixed or only temporarily affixed), to allow the layers to unfold within the disc cavity. Such unfolding may, for example, participate in configuring the device to resist expulsion from an annulus fibrosis opening, and/or to occupy a modified volume within the disc cavity for supporting tissue ingrowth. - Although a generally cylindrical disc repair device is shown in FIGS. 1 and 2, the device may assume a variety of other configurations including spherical, rectangular, conical, ring, and other shapes. It is preferred that the device be shaped so that it can facilitate blocking an opening in the annulus fibrosus of a damaged intervertebral disc when positioned in the disc cavity. For example, the device may have a first end having a cross-sectional dimension smaller than another cross-sectional dimension along the device, for example having an increasing cross-sectional dimension along the device length such as occurs in a generally conical device. Referring now to FIG. 3, such a
disc repair device 21 is shown, having a generally conical shape with alarger end 22 and anouter surface 23 that tapers towards a smaller opposingend 24. As another example, the device may be collapsible in upon itself to have a smaller overall cross-sectional dimension in a direction in which it is to be inserted, for example in the case of an annular ring. Shown in FIG. 4 is such adisc treatment device 31, having the shape of an annular ring.Device 31 preferably has an outer diameter, when expanded, approximating the horizontal width of the disc cavity, and can be collapsed upon itself to adopt a smaller overall cross-sectional dimension for insertion through an opening in the annulus fibrosis. - With reference now to FIG. 5, shown is a side cross-sectional view of a intervertebral disc having positioned therein
disc treatment device 11 of FIG. 1. As illustrated, anintervertebral disc 41 includes theannulus fibrosus 42 formed from multiple layers of type II collagenous tissue, bounding aninternal disc cavity 43.Disc treatment device 11 is sized and configured to be contained within the disc cavity and in the illustrated embodiment has a vertical dimension to contact the upper and lower surfaces of the disc cavity formed by end plates of adjacent vertebrae. In addition,device 11 has a horizontal dimension substantially spanning the horizontal width of thedisc cavity 43.Device 11 also abuts the inner surface of theannulus fibrosus 42 so as to facilitate blockage of effluence fromdisc cavity 43 via opening 44 inannulus fibrosus 42.Opening 44 inannulus fibrosis 42 often occurs posterolaterally, where the annulus fibrosis is no longer supported by the posterior longitudinal ligament. Thus, in most cases,device 11 or other disc treatment devices of the invention can be inserted via a posterolateral approach, although other approaches may be used which correspond to the location of the rupture in the disc to be treated, or which involve insertion of the device through a conservative, alternate opening created in a spaced location from the rupture. - With reference now to FIGS. 6, 7, and8, shown are superior views of
disc treatment devices - The disc treatment devices of the invention may be formed from a wide variety of natural and/or synthetic materials, preferably natural and/or synthetic polymers. Natural polymers include, for example, collagen, elastin, and cellulose and may be obtained from natural sources by methods known to the skilled artisan, synthesized by methods known to those skilled in the art, or may be obtained commercially. Synthetic polymers which may be used in the present invention include, for example, polyamides, polyesters (e.g., Dacron), polyethylene, polyacrylonitrile, polyurethanes, polypropylenes or mixtures thereof. Combinations of natural and synthetic materials may also form an appropriate fibrous body for use in the present invention.
- The preferred devices of the invention advantageously incorporate a tissue growth factor. In one embodiment, the device includes a liquid or solid carrier containing the tissue growth factor. For example, a solid or liquid carrier containing the growth factor may be used to coat the exterior of the device, and/or may be incorporated within interstitial spaces (e.g. pores) occurring internally of the device. In addition, or alternatively, a solid carrier matrix containing the growth factor may be used to coat individual fibers from which the body of the disc treatment device is formed. The growth factor is generally suited to promote the formation of tissues, especially of the type(s) naturally occurring as internal or external components of the disc. For instance, the growth factor may promote the growth or viability of tissue or cell types occurring in the nucleus pulposus such as nucleus pulposus cells and chondrocytes, as well as space filling cells such as fibroblasts and connective tissue cells such as ligament and tendon cells. Alternatively or in addition, the growth factor may promote the growth or viability of tissue types occurring in the annulus fibrosus, as well as space filling cells such as fibroblasts and connective tissue cells such as ligament and tendon cells. Such growth factors include Transforming Growth Factor-beta (TGF-B) and members of the TGF-B superfamily, Fibroblast Growth Factor (FGF) and members of the FGF family, Platelet Derived Growth Factor (PDGF) and members of the PDGF family, members of the hedgehog family of proteins, interleukins, Insulin-like Growth Factor (IGF) and members of the IGF family, colony-stimulating factor (CSF) and members of the CSF family, Growth Differentiation Factors (GDFs), Cartilage Derived Growth Factors (CDGFs), Cartilage Derived Morphogenic Proteins (CDMPs), Bone Morphogenetic Proteins (BMPs), and mixtures thereof. BMPs are preferred.
- A wide variety of BMPs have been identified and may be used in the present invention. Human BMPs, especially recombinant human BMPs, are preferred, including for
instance BMPs - In one aspect of the invention, BMP-12 and/or BMP-13 will be employed in an effective amount to stimulate growth of ligament and/or tendon connective tissue within the disc cavity, for instance as may be evidenced by increased synthesis of proteoglycans and collagens. Recombinant human BMP-13 is most preferred in this regard.
- A wide variety of materials may be utilized as solid carriers. Examples include natural polymers such as collagen, gelatin, elastin, cellulose, and the like.
- In one preferred embodiment, the carrier is collagen. A wide variety of types of collagen may be used, including type I (found primarily in skin, tendon and bone), type II (found in cartilage), type III (found primarily in skin), fibrillar and non-fibrillar collagen. The collagen may be isolated from skin, bone, tendon, or cartilage by methods known to the skilled artisan and may be purified by methods known in the art. Alternately, the collagen may be purchased commercially. Moreover, atelopeptidic or telopeptidic collagen may be used.
- In methods for disc treatment, the tissue growth factor may be applied to the device as described above or may be introduced into the disc space or cavity separately (e.g. by injection), or by recombinant DNA methods. For example, a nucleic acid sequence, such as a deoxyribonucleic acid sequence, encoding the particular growth factor, or an active fragment thereof, may be introduced into an appropriate vector. The vector may be a wide variety of vectors typically used in gene transfer protocols, including, for example, retroviral vectors or adenovirus vectors. The vector construct may be synthesized by methods known to the skilled artisan. The nucleic acid sequence may be under the control of, and operably linked to, a promoter or other regulatory sequence known in the art. The promoter is preferably one which may be activated in the target cell by regulatory elements present in the target cell.
- In one form of the invention, the disc repair device advantageously includes a therapeutically effective amount of the tissue growth factor. What constitutes an effective amount will vary depending on factors known to the skilled artisan, such as the specific growth factor used and the extent and type of the damage to the intervertebral disc. However, the disc repair device will typically contain about 2 mg to about 20 mg of the growth factor. When BMP-9 is used, for example, amounts applied may include about 8 mg to about 12 mg.
- In another aspect of the invention, an intervertebral disc treatment apparatus is provided that includes a disc repair device as described above in combination with a delivery apparatus. Referring now to FIG. 11,
apparatus 61 is shown that includes the generally conicaldisc repair device 21 of FIG. 3, in compressed configuration within the apparatus. Thedisc treatment apparatus 61 includes tubular orbarrel member 62 having proximal end, a distal end, and alumen 63 extending longitudinally therethrough.Member 62 may be similar to the barrel of a syringe as known in the art.Lumen 63 is configured for housing the disc repair device.Member 62 may be constructed of a wide variety of materials, including polytetrafluoroethylene (Teflon), polyethylene, polyurethane, nylon, glass, or combinations thereof. - Disc
repair delivery apparatus 61 further includes atranslation member 64 at the proximal end oftubular member 62 or forcing thedisc repair device 21 distally throughlumen 63, through an opening in the annulus fibrosus of a damaged disc, and into the disc cavity of the disc.Translation member 64 may be an elongated member sized to at least partially fit withinlumen 63 ofmember 62 and which is capable of pushing the disc repair device distally alonglumen 63. For example,member 64 may be a plunger including ahandle 67, anelongate rod 66, and aninternal member 65 substantially spanning thelumen 63 oftubular member 62, as seen in FIG. 8. Alternately,translation member 64 may be replaced by other means for translatingdevice 21 alonglumen 63. For example fluid (e.g. liquid) driven mechanisms may be used. The disc repair device, such asdisc repair device 21, is preferably placed in a collapsed or compressed conformation as shown in FIG. 11, advantageously by manual force, prior to or upon positioning thedevice 21 inlumen 63 shown in FIG. 12 is a similardisc treatment apparatus 71 except including thereindevice 31 of FIG. 4 in compressed configuration, instead ofdevice 21 of FIG. 3. - In another aspect of the invention, methods of treating an intervertebral disc are provided. In one embodiment, a method of treating an intervertebral disc includes providing a disc treatment device as described above, such as a fibrous body sized for introduction into an opening of an annulus fibrosus of a damaged intervertebral disc, and inserting the fibrous body into and through the opening, and blocking effluence from the opening.
- In order to place the disc repair device in the disc cavity, a disc
repair delivery apparatus lumen 63 oftubular member 62 is aligned with the opening in the annulus fibrosus of an intervertebral disc so that the disc repair device may be pushed distally alonglumen 63, through the opening in the annulus and into the disc cavity. The disc repair device will then adopt an expanded conformation as seen in FIG. 14. - Referring now to FIG. 15, shown is an alternative disc treatment device70, having a generally
bulbous end 71 and a generallycylindrical end 72.Bulbous end 71 has a greatest cross-sectional diameter greater than that ofcylindrical end 72. In one mode of use, device 70 can be compressed and loaded into a cylindrical delivery apparatus, and delivered through a hole in the annulus and into the disc cavity, preferably first introducingbulbous end 71. Device 70 can then expand within the disc cavity. - With reference now to FIGS.16-18, illustrated is one mode of introducing an elongate implant body through an
opening 75 in an annulus 76 (e.g. in the location of a rupture opening), and into thedisc cavity 77. An elongate,cylindrical implant 78 is provided (e.g. a Dacron mesh cylinder) having aninternal suture 79 or other similar structure running therethrough and tied off or otherwise connected at anend 80 ofimplant 78. The other end ofsuture 79 is tied to acurved needle 81. To deliver theimplant 78,implant 78 can be loaded within arigid tube 82, withneedle 81 and an exposed length ofsuture 79 extending therefrom.Needle 81 can be passed throughopening 75 inannulus 76 and into thedisc cavity 77, and then back through theannulus 76 at a spaced location from opening 75, for example at an opposite, posterolateral position which can be surgically accessed separately.Suture 79 can then be pulled to in turn pullimplant 78 into thedisc cavity 77.Suture 79 can then be closely cut or broken so as to partially retract into the annulus. - FIG. 19 illustrates another apparatus and method for delivering an
implant 85, such as a cylindrical Dacron mesh implant, into a disc cavity.Implant 85 is loaded within arigid cannula tube 86, which in turn is passed through the opening in the annulus. In this regard,implant 85 can be loaded in a dry or wet state, preferably a dry, compressed state.Implant 85 is then advanced through thetube 86 using push orplunger rod 87, and into the disc cavity. After implantation, adry implant 85 will hydrate, and preferably swell, in situ in the disc cavity. If desired, the internal surface of thetube 86 and the exterior surface of therod 87 can be provided with respective cooperating members, such as threads, to assist in controllably advancingimplant 85 through thetube 86. For example, the inner surface oftube 86 may bear threads, while the external surface ofrod 87 bears corresponding threads. In this fashion, rotation ofrod 87 in relation totube 86 will advancerod 87 throughtube 86, thereby pushingimplant 85 throughtube 86. In addition, or in the alternative, theimplant 85 and/or the internal surface oftube 86 may be coated with a suitable, biocompatible lubricant to reduce the friction between theimplant 85 and thetube 86 during the advancement operation. - Referring now to FIGS. 20 and 21, shown is another apparatus and method for delivering an implant through an annulus opening and into the disc cavity. A
rigid cannula tube 90 defines an opening such as a slot 91 in a sidewall thereof. A plurality of openings (e.g. opposed slots) may also be provided. Afriction member 92 is mounted overtube 90 and includes an engagingportion 93 extending into slot 91 so as to provide frictional contact with animplant 94 insidetube 90. In this fashion,implant 94 can be advanced throughtube 90 by corresponding advancement of thefriction member 92 while its engagingportion 93 frictionally engagesimplant 94 through slot 91. In this regard, the frictional engagement of theimplant 94 can optionally be facilitated by the presence of teeth 95 (e.g. directional as shown) or other roughened surface features such as grooves or proturbances on the engagingportion 93 offriction member 92, and/or by selection of materials exhibiting a coefficient of friction with the implant suitably high to effectively advance the implant through thetube 90. Further, the frictional engagement of engagingportion 93 withimplant 94 may be releasable, for example by constructing adeflectable friction member 92 which in a relaxed state disengages engagingportion 93 from the implant, but in a compressed state (e.g. by manually squeezing) engages engagingportion 93 with theimplant 94, or vice versa. - A tissue growth factor may be provided on the body of or within the device, separately within the disc space of the intervertebral disc, or both. When included separately in the disc space, the tissue growth factor may be provided within the disc space either before or after the disc repair device is positioned. Injection of an aqueous fluid containing the tissue growth factor into the disc repair device may also facilitate expansion of a hydratable, swellable disc repair device immediately after implantation. The disc repair device may be adapted and dimensional such that when in its expanded or swollen conformation, the device is of a sufficiently large dimension to contact the overlying and underlying endplates, preferably under compression, so as to secure the device in place in the disc cavity and desirably dissipate compressive loads from the spine.
- All or a portion of the nucleus pulposus of a damaged intervertebral disc may be removed prior to inserting the device. Moreover, the method may also be followed for preventing escape of the nucleus pulposus from a damaged intervertebral disc, as the disc repair devices of the present invention may act as a plug.
- It will be understood that various ways of orienting a disc repair device of the present invention in disc cavity are contemplated in the invention. A single disc repair device can have its longitudinal axis positioned perpendicular to longitudinal axis of the vertebral column, or two or more devices can be positioned in this manner (e.g. two devices used in a bilateral configuration).
- Disc treatment devices may be inserted through pre-existing (e.g. rupture) opening in the annulus fibrosus or they may be inserted through a cut or incised opening. In one preferred manner of carrying out the invention, the one or more devices provided to the disc cavity will substantially fill the existing void in the cavity, and may also have a sufficient vertical dimension to contact the upper and lower surfaces within the cavity, for instance so as to be effective to absorb compressive loads of the spine.
- Delivery apparatuses in accordance with the invention may also be adapted for non- or minimally-invasive delivery of the intervertebral disc treatment device. For example, such an apparatus can include a cannulated device of sufficient length to extend to the disc cavity from an exterior operating position, and the disc treatment device can be advanced (e.g. in compressed or collapsed form) through and out the distal end of the cannula and into the disc cavity. For example, such a procedure may immediately follow a known discectomy protocol, including for instance microdiscectomies, endoscopic discectomies, and laparoscopic discectomies. Further, the delivery of the disc treatment device may be conducted under endoscopic or other similar visualization techniques.
- While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiment has been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected. In addition, all references cited herein are indicative of the level of skill in the art and are hereby incorporated by reference in their entirety.
Claims (56)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/165,347 US20020173851A1 (en) | 1999-12-06 | 2002-06-06 | Intervertebral disc treatment devices and methods |
US10/990,823 US7318840B2 (en) | 1999-12-06 | 2004-11-17 | Intervertebral disc treatment devices and methods |
US11/877,235 US8349012B2 (en) | 1999-12-06 | 2007-10-23 | Intervertebral disc treatment devices and methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16914899P | 1999-12-06 | 1999-12-06 | |
PCT/US2000/042610 WO2001045577A2 (en) | 1999-12-06 | 2000-12-06 | Intervertebral disc treatment devices and methods |
US10/165,347 US20020173851A1 (en) | 1999-12-06 | 2002-06-06 | Intervertebral disc treatment devices and methods |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/042610 Division WO2001045577A2 (en) | 1999-12-06 | 2000-12-06 | Intervertebral disc treatment devices and methods |
PCT/US2000/042610 Continuation WO2001045577A2 (en) | 1999-12-06 | 2000-12-06 | Intervertebral disc treatment devices and methods |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/990,823 Continuation US7318840B2 (en) | 1999-12-06 | 2004-11-17 | Intervertebral disc treatment devices and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020173851A1 true US20020173851A1 (en) | 2002-11-21 |
Family
ID=22614410
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/165,347 Abandoned US20020173851A1 (en) | 1999-12-06 | 2002-06-06 | Intervertebral disc treatment devices and methods |
US10/990,823 Expired - Lifetime US7318840B2 (en) | 1999-12-06 | 2004-11-17 | Intervertebral disc treatment devices and methods |
US11/877,235 Expired - Lifetime US8349012B2 (en) | 1999-12-06 | 2007-10-23 | Intervertebral disc treatment devices and methods |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/990,823 Expired - Lifetime US7318840B2 (en) | 1999-12-06 | 2004-11-17 | Intervertebral disc treatment devices and methods |
US11/877,235 Expired - Lifetime US8349012B2 (en) | 1999-12-06 | 2007-10-23 | Intervertebral disc treatment devices and methods |
Country Status (10)
Country | Link |
---|---|
US (3) | US20020173851A1 (en) |
EP (1) | EP1244388B1 (en) |
JP (1) | JP4672947B2 (en) |
AU (1) | AU774481B2 (en) |
CA (1) | CA2392721C (en) |
CY (1) | CY1106498T1 (en) |
DE (1) | DE60033055D1 (en) |
DK (1) | DK1244388T3 (en) |
ES (1) | ES2278648T3 (en) |
WO (1) | WO2001045577A2 (en) |
Cited By (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040117019A1 (en) * | 2000-08-30 | 2004-06-17 | Trieu Hai H. | Method and apparatus for delivering an intervertebral disc implant |
US20050149046A1 (en) * | 2003-12-24 | 2005-07-07 | Friedman Craig D. | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
US20050209601A1 (en) * | 2004-03-22 | 2005-09-22 | Disc Dynamics, Inc. | Multi-stage biomaterial injection system for spinal implants |
US20060136065A1 (en) * | 2004-12-16 | 2006-06-22 | Replication Medical Inc. | Radially compressed dehydrated spinal nucleus implants |
US20060247783A1 (en) * | 2005-04-30 | 2006-11-02 | Mckay William F | Spinal fusion with osteogenic material and migration barrier |
US20070003598A1 (en) * | 2003-08-06 | 2007-01-04 | Warsaw Orthopedic, Inc. | Osteogenic implants for soft tissue |
US7267687B2 (en) | 2001-10-02 | 2007-09-11 | Rex Medical, L.P | Spinal implant and method of use |
US20070250045A1 (en) * | 2006-04-24 | 2007-10-25 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for osteal growth |
US20070250044A1 (en) * | 2006-04-24 | 2007-10-25 | Sdgi Holdings, Inc. | Controlled release systems and methods for intervertebral discs |
US20070250046A1 (en) * | 2006-04-24 | 2007-10-25 | Sdgi Holdings, Inc. | Controlled release devices for therapeutic treatments of spinal discs |
US20070270844A1 (en) * | 2004-11-03 | 2007-11-22 | The Regents Of The University Of Michigan | Biodegradable implant for intertransverse process fusion |
US20070276337A1 (en) * | 2006-04-24 | 2007-11-29 | Warsaw Orthopedic, Inc. | Controlled release devices for fusion of osteal structures |
WO2007100591A3 (en) * | 2006-02-22 | 2008-01-31 | Ouroboros Inc | Mechanical apparatus and method for artificial disc replacement |
US20080065218A1 (en) * | 2006-09-13 | 2008-03-13 | O'neil Michael J | Annulus fibrosus repair devices and techniques |
US20080133012A1 (en) * | 2006-11-16 | 2008-06-05 | Mcguckin James F | Spinal implant and method of use |
US20080172126A1 (en) * | 2006-10-03 | 2008-07-17 | Reynolds Martin A | Nucleus pulposus injection devices and methods |
WO2008101300A1 (en) * | 2007-02-23 | 2008-08-28 | Cellixe Pty Ltd | Composition and method for the treatment or prevention of spinal disorders |
US20090082719A1 (en) * | 2005-05-03 | 2009-03-26 | Yeung Jeffrey E | Injection device for the intervertebral disc |
US7666227B2 (en) | 2005-08-16 | 2010-02-23 | Benvenue Medical, Inc. | Devices for limiting the movement of material introduced between layers of spinal tissue |
US7727263B2 (en) | 2000-02-16 | 2010-06-01 | Trans1, Inc. | Articulating spinal implant |
US7740633B2 (en) | 2003-10-23 | 2010-06-22 | Trans1 Inc. | Guide pin for guiding instrumentation along a soft tissue tract to a point on the spine |
US7753941B2 (en) | 2000-04-04 | 2010-07-13 | Anulex Technologies, Inc. | Devices and methods for annular repair of intervertebral discs |
US7803395B2 (en) | 2003-05-15 | 2010-09-28 | Biomerix Corporation | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
US7976549B2 (en) | 2006-03-23 | 2011-07-12 | Theken Spine, Llc | Instruments for delivering spinal implants |
US7988695B2 (en) | 2005-12-21 | 2011-08-02 | Theken Spine, Llc | Articulated delivery instrument |
US7988735B2 (en) * | 2005-06-15 | 2011-08-02 | Matthew Yurek | Mechanical apparatus and method for delivering materials into the inter-vertebral body space for nucleus replacement |
US20110213402A1 (en) * | 2005-05-24 | 2011-09-01 | Kyphon Sarl | Low-compliance expandable medical device |
US8012211B2 (en) * | 2002-11-05 | 2011-09-06 | Spineology, Inc. | Semi-biological intervertebral disc replacement system |
US8070818B2 (en) | 2005-04-29 | 2011-12-06 | Jmea Corporation | Disc annulus repair system |
US8092548B2 (en) | 2005-06-22 | 2012-01-10 | Warsaw Orthopedic, Inc. | Osteograft treatment to promote osteoinduction and osteograft incorporation |
US8128698B2 (en) | 1999-10-20 | 2012-03-06 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8163022B2 (en) | 2008-10-14 | 2012-04-24 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8211126B2 (en) | 2009-09-22 | 2012-07-03 | Jmea Corporation | Tissue repair system |
US8366773B2 (en) | 2005-08-16 | 2013-02-05 | Benvenue Medical, Inc. | Apparatus and method for treating bone |
US8454617B2 (en) | 2005-08-16 | 2013-06-04 | Benvenue Medical, Inc. | Devices for treating the spine |
US8460319B2 (en) | 2010-01-11 | 2013-06-11 | Anulex Technologies, Inc. | Intervertebral disc annulus repair system and method |
US8506636B2 (en) | 2006-09-08 | 2013-08-13 | Theken Spine, Llc | Offset radius lordosis |
US8535327B2 (en) | 2009-03-17 | 2013-09-17 | Benvenue Medical, Inc. | Delivery apparatus for use with implantable medical devices |
US8556977B2 (en) | 1999-10-20 | 2013-10-15 | Anulex Technologies, Inc. | Tissue anchoring system and method |
US8591583B2 (en) | 2005-08-16 | 2013-11-26 | Benvenue Medical, Inc. | Devices for treating the spine |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
US8702718B2 (en) | 2005-04-29 | 2014-04-22 | Jmea Corporation | Implantation system for tissue repair |
US8814873B2 (en) | 2011-06-24 | 2014-08-26 | Benvenue Medical, Inc. | Devices and methods for treating bone tissue |
US9095442B2 (en) | 1999-10-20 | 2015-08-04 | Krt Investors, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US9114025B2 (en) | 1999-10-20 | 2015-08-25 | Krt Investors, Inc. | Methods and devices for spinal disc annulus reconstruction and repair |
US9737294B2 (en) | 2013-01-28 | 2017-08-22 | Cartiva, Inc. | Method and system for orthopedic repair |
US9788963B2 (en) | 2003-02-14 | 2017-10-17 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US9814598B2 (en) | 2013-03-14 | 2017-11-14 | Quandary Medical, Llc | Spinal implants and implantation system |
US10085783B2 (en) | 2013-03-14 | 2018-10-02 | Izi Medical Products, Llc | Devices and methods for treating bone tissue |
US10179012B2 (en) | 2013-01-28 | 2019-01-15 | Cartiva, Inc. | Systems and methods for orthopedic repair |
US10888433B2 (en) | 2016-12-14 | 2021-01-12 | DePuy Synthes Products, Inc. | Intervertebral implant inserter and related methods |
US10940016B2 (en) | 2017-07-05 | 2021-03-09 | Medos International Sarl | Expandable intervertebral fusion cage |
US10966840B2 (en) | 2010-06-24 | 2021-04-06 | DePuy Synthes Products, Inc. | Enhanced cage insertion assembly |
US10973652B2 (en) | 2007-06-26 | 2021-04-13 | DePuy Synthes Products, Inc. | Highly lordosed fusion cage |
US11213402B2 (en) | 2017-01-11 | 2022-01-04 | Loubert S. Suddaby | Endoscopically implantable inflatable interbody fusion device |
US11273050B2 (en) | 2006-12-07 | 2022-03-15 | DePuy Synthes Products, Inc. | Intervertebral implant |
US11344424B2 (en) | 2017-06-14 | 2022-05-31 | Medos International Sarl | Expandable intervertebral implant and related methods |
US11426290B2 (en) | 2015-03-06 | 2022-08-30 | DePuy Synthes Products, Inc. | Expandable intervertebral implant, system, kit and method |
US11426286B2 (en) | 2020-03-06 | 2022-08-30 | Eit Emerging Implant Technologies Gmbh | Expandable intervertebral implant |
US11446155B2 (en) | 2017-05-08 | 2022-09-20 | Medos International Sarl | Expandable cage |
US11446156B2 (en) | 2018-10-25 | 2022-09-20 | Medos International Sarl | Expandable intervertebral implant, inserter instrument, and related methods |
US11452607B2 (en) | 2010-10-11 | 2022-09-27 | DePuy Synthes Products, Inc. | Expandable interspinous process spacer implant |
US11497619B2 (en) | 2013-03-07 | 2022-11-15 | DePuy Synthes Products, Inc. | Intervertebral implant |
US11510788B2 (en) | 2016-06-28 | 2022-11-29 | Eit Emerging Implant Technologies Gmbh | Expandable, angularly adjustable intervertebral cages |
US11596522B2 (en) | 2016-06-28 | 2023-03-07 | Eit Emerging Implant Technologies Gmbh | Expandable and angularly adjustable intervertebral cages with articulating joint |
US11602438B2 (en) | 2008-04-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Expandable intervertebral implant |
US11607321B2 (en) | 2009-12-10 | 2023-03-21 | DePuy Synthes Products, Inc. | Bellows-like expandable interbody fusion cage |
US11612491B2 (en) | 2009-03-30 | 2023-03-28 | DePuy Synthes Products, Inc. | Zero profile spinal fusion cage |
US11654033B2 (en) | 2010-06-29 | 2023-05-23 | DePuy Synthes Products, Inc. | Distractible intervertebral implant |
US11737881B2 (en) | 2008-01-17 | 2023-08-29 | DePuy Synthes Products, Inc. | Expandable intervertebral implant and associated method of manufacturing the same |
US11752009B2 (en) | 2021-04-06 | 2023-09-12 | Medos International Sarl | Expandable intervertebral fusion cage |
US11850160B2 (en) | 2021-03-26 | 2023-12-26 | Medos International Sarl | Expandable lordotic intervertebral fusion cage |
US11911287B2 (en) | 2010-06-24 | 2024-02-27 | DePuy Synthes Products, Inc. | Lateral spondylolisthesis reduction cage |
Families Citing this family (149)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040081704A1 (en) | 1998-02-13 | 2004-04-29 | Centerpulse Biologics Inc. | Implantable putty material |
US20060247665A1 (en) | 1999-05-28 | 2006-11-02 | Ferree Bret A | Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft |
US20070038231A1 (en) | 1999-05-28 | 2007-02-15 | Ferree Bret A | Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft |
US7273497B2 (en) | 1999-05-28 | 2007-09-25 | Anova Corp. | Methods for treating a defect in the annulus fibrosis |
EP1328221B1 (en) * | 1999-08-18 | 2009-03-25 | Intrinsic Therapeutics, Inc. | Devices for nucleus pulposus augmentation and retention |
US20040024465A1 (en) * | 1999-08-18 | 2004-02-05 | Gregory Lambrecht | Devices and method for augmenting a vertebral disc |
EP1624832A4 (en) * | 1999-08-18 | 2008-12-24 | Intrinsic Therapeutics Inc | Devices and method for augmenting a vertebral disc nucleus |
US8323341B2 (en) * | 2007-09-07 | 2012-12-04 | Intrinsic Therapeutics, Inc. | Impaction grafting for vertebral fusion |
US7553329B2 (en) * | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
US7998213B2 (en) * | 1999-08-18 | 2011-08-16 | Intrinsic Therapeutics, Inc. | Intervertebral disc herniation repair |
US7972337B2 (en) * | 2005-12-28 | 2011-07-05 | Intrinsic Therapeutics, Inc. | Devices and methods for bone anchoring |
US6508839B1 (en) | 1999-08-18 | 2003-01-21 | Intrinsic Orthopedics, Inc. | Devices and methods of vertebral disc augmentation |
US7220281B2 (en) | 1999-08-18 | 2007-05-22 | Intrinsic Therapeutics, Inc. | Implant for reinforcing and annulus fibrosis |
US6936072B2 (en) | 1999-08-18 | 2005-08-30 | Intrinsic Therapeutics, Inc. | Encapsulated intervertebral disc prosthesis and methods of manufacture |
US7717961B2 (en) | 1999-08-18 | 2010-05-18 | Intrinsic Therapeutics, Inc. | Apparatus delivery in an intervertebral disc |
US6821276B2 (en) | 1999-08-18 | 2004-11-23 | Intrinsic Therapeutics, Inc. | Intervertebral diagnostic and manipulation device |
US20030153976A1 (en) * | 1999-10-20 | 2003-08-14 | Cauthen Joseph C. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US6592625B2 (en) | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US20020026244A1 (en) * | 2000-08-30 | 2002-02-28 | Trieu Hai H. | Intervertebral disc nucleus implants and methods |
JP2004507318A (en) * | 2000-08-30 | 2004-03-11 | エスディージーアイ・ホールディングス・インコーポレーテッド | Disc nucleus pulposus implant and method |
US6846319B2 (en) | 2000-12-14 | 2005-01-25 | Core Medical, Inc. | Devices for sealing openings through tissue and apparatus and methods for delivering them |
US6896692B2 (en) | 2000-12-14 | 2005-05-24 | Ensure Medical, Inc. | Plug with collet and apparatus and method for delivering such plugs |
US8083768B2 (en) | 2000-12-14 | 2011-12-27 | Ensure Medical, Inc. | Vascular plug having composite construction |
US6623509B2 (en) | 2000-12-14 | 2003-09-23 | Core Medical, Inc. | Apparatus and methods for sealing vascular punctures |
US6890343B2 (en) | 2000-12-14 | 2005-05-10 | Ensure Medical, Inc. | Plug with detachable guidewire element and methods for use |
US20020114795A1 (en) * | 2000-12-22 | 2002-08-22 | Thorne Kevin J. | Composition and process for bone growth and repair |
US20070142791A1 (en) * | 2003-05-07 | 2007-06-21 | Aleeve Medical Inc. A Delaware Corporation | U-shaped disc shunt and delivery device |
AU2004249291B2 (en) * | 2003-06-20 | 2009-07-23 | Intrinsic Therapeutics, Inc. | Device and method for delivering an implant through an annular defect in an intervertebral disc |
US8852229B2 (en) | 2003-10-17 | 2014-10-07 | Cordis Corporation | Locator and closure device and method of use |
US7361183B2 (en) | 2003-10-17 | 2008-04-22 | Ensure Medical, Inc. | Locator and delivery device and method of use |
WO2005089679A1 (en) * | 2004-02-17 | 2005-09-29 | Frederic Fortin | Intervertebral annulus prosthesis |
FR2866227B1 (en) * | 2004-02-17 | 2007-07-13 | Frederic Fortin | PROSTHESIS OF ANULUS INTERVERTEBRAL |
WO2005092247A1 (en) * | 2004-03-26 | 2005-10-06 | Nuvasive Inc. | Prosthetic spinal disc |
WO2005115438A1 (en) * | 2004-05-25 | 2005-12-08 | Stryker Corporation | Use of morphogenic proteins for treating cartilage defects |
US20060074422A1 (en) * | 2004-09-27 | 2006-04-06 | Story Brooks J | Suture anchor and void filler combination |
EP1814474B1 (en) | 2004-11-24 | 2011-09-14 | Samy Abdou | Devices for inter-vertebral orthopedic device placement |
CN101132748B (en) * | 2005-03-01 | 2010-06-16 | 斯拜恩塞尔有限公司 | Intervertebral disc restoration |
US8088144B2 (en) | 2005-05-04 | 2012-01-03 | Ensure Medical, Inc. | Locator and closure device and method of use |
US8926654B2 (en) | 2005-05-04 | 2015-01-06 | Cordis Corporation | Locator and closure device and method of use |
US8021426B2 (en) | 2005-06-15 | 2011-09-20 | Ouroboros Medical, Inc. | Mechanical apparatus and method for artificial disc replacement |
US7442210B2 (en) | 2005-06-15 | 2008-10-28 | Jerome Segal | Mechanical apparatus and method for artificial disc replacement |
US7601172B2 (en) * | 2005-06-15 | 2009-10-13 | Ouroboros Medical, Inc. | Mechanical apparatus and method for artificial disc replacement |
US20070162135A1 (en) * | 2005-06-15 | 2007-07-12 | Jerome Segal | Mechanical apparatus and method for artificial disc replacement |
US20070093905A1 (en) * | 2005-10-21 | 2007-04-26 | O'neil Michael J | Degenerative disc regeneration techniques |
WO2007057908A2 (en) * | 2005-11-21 | 2007-05-24 | Nicast Ltd. | Spinal nucleus prosthesis device |
WO2007075411A2 (en) * | 2005-12-16 | 2007-07-05 | Thomas Haider Patents, A Limited Liability Company | An intervertebral prosthesis for supporting adjacent vertebral bodies enabling the creation of soft fusion and method |
US8478300B2 (en) * | 2005-12-20 | 2013-07-02 | Microsoft Corporation | Proximity service discovery in wireless networks |
US7613426B2 (en) | 2005-12-20 | 2009-11-03 | Microsoft Corporation | Proximity service discovery in wireless networks |
US8559350B2 (en) * | 2005-12-20 | 2013-10-15 | Microsoft Corporation | Mechanism to convey discovery information in a wireless network |
US20070161962A1 (en) * | 2006-01-09 | 2007-07-12 | Edie Jason A | Device and method for moving fill material to an implant |
EP1991284A4 (en) * | 2006-02-01 | 2012-07-04 | Jake Barralet | Bioimplants for use in tissue growth |
US20070270970A1 (en) * | 2006-03-14 | 2007-11-22 | Sdgi Holdings, Inc. | Spinal implants with improved wear resistance |
US7993404B2 (en) * | 2006-03-29 | 2011-08-09 | Warsaw Orthopedic, Inc. | Transformable spinal implants and methods of use |
US20070233246A1 (en) * | 2006-03-31 | 2007-10-04 | Sdgi Holdings, Inc. | Spinal implants with improved mechanical response |
US10681151B2 (en) | 2006-05-15 | 2020-06-09 | Microsoft Technology Licensing, Llc | Notification framework for wireless networks |
US8834496B2 (en) | 2006-06-13 | 2014-09-16 | Bret A. Ferree | Soft tissue repair methods and apparatus |
US9232938B2 (en) | 2006-06-13 | 2016-01-12 | Anova Corp. | Method and apparatus for closing fissures in the annulus fibrosus |
US8399619B2 (en) | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
US7758649B2 (en) * | 2006-08-04 | 2010-07-20 | Integrity Intellect Inc. | Reversibly deformable implant |
US20080077150A1 (en) * | 2006-09-22 | 2008-03-27 | Linh Nguyen | Steerable rasp/trial member inserter and method of use |
EP2086507B1 (en) * | 2006-10-06 | 2018-11-07 | BioNet Pharma GmbH | A spinal nucleus pulposus implant |
US8066750B2 (en) | 2006-10-06 | 2011-11-29 | Warsaw Orthopedic, Inc | Port structures for non-rigid bone plates |
AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
US7718616B2 (en) * | 2006-12-21 | 2010-05-18 | Zimmer Orthobiologics, Inc. | Bone growth particles and osteoinductive composition thereof |
WO2008080147A2 (en) * | 2006-12-22 | 2008-07-03 | Pioneer Surgical Technology, Inc. | Implant retention device and methods |
US20080249529A1 (en) * | 2007-03-15 | 2008-10-09 | Depuy Spine, Inc. | Dual incision disc repair device and method |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
US8681691B2 (en) | 2007-07-25 | 2014-03-25 | Microsoft Corporation | Base station initiated proximity service discovery and connection establishment |
US8092541B2 (en) * | 2007-08-03 | 2012-01-10 | Warsaw Orthopedic, Inc. | Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors |
CN101801405A (en) | 2007-08-07 | 2010-08-11 | 先进科技及再生医学有限责任公司 | Be contained in the protein formulations of the GDF-5 in the acidic aqueous solution |
US8282681B2 (en) | 2007-08-13 | 2012-10-09 | Nuvasive, Inc. | Bioresorbable spinal implant and related methods |
US20110196492A1 (en) | 2007-09-07 | 2011-08-11 | Intrinsic Therapeutics, Inc. | Bone anchoring systems |
US9105031B2 (en) | 2008-02-22 | 2015-08-11 | Microsoft Technology Licensing, Llc | Authentication mechanisms for wireless networks |
US8377135B1 (en) | 2008-03-31 | 2013-02-19 | Nuvasive, Inc. | Textile-based surgical implant and related methods |
US20110029087A1 (en) * | 2008-04-04 | 2011-02-03 | Haider Thomas T | Intervertebral prostheses with compliant filler material for supporting adjacent vertebral bodies and method |
WO2009129101A1 (en) * | 2008-04-14 | 2009-10-22 | Advanced Technologies And Regenerative Medicine, Llc | Liquid buffered gdf-5 formulations |
US8722079B2 (en) | 2008-04-18 | 2014-05-13 | Warsaw Orthopedic, Inc. | Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine |
US20090264477A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc., An Indiana Corporation | Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
US8629172B2 (en) | 2008-04-18 | 2014-01-14 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising clonidine |
US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US9072727B2 (en) | 2008-04-18 | 2015-07-07 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
US9132085B2 (en) | 2008-04-18 | 2015-09-15 | Warsaw Orthopedic, Inc. | Compositions and methods for treating post-operative pain using clonidine and bupivacaine |
US20090263443A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedics, Inc. | Methods for treating post-operative effects such as spasticity and shivering with clondine |
US8956636B2 (en) | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Methods and compositions for treating postoperative pain comprosing ketorolac |
US8956641B2 (en) | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
US9289409B2 (en) * | 2008-04-18 | 2016-03-22 | Warsaw Orthopedic, Inc. | Sulindac formulations in a biodegradable material |
US20090263451A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain |
US9125917B2 (en) * | 2008-04-18 | 2015-09-08 | Warsaw Orthopedic, Inc. | Fluocinolone formulations in a biodegradable polymer carrier |
US8883768B2 (en) * | 2008-04-18 | 2014-11-11 | Warsaw Orthopedic, Inc. | Fluocinolone implants to protect against undesirable bone and cartilage destruction |
US8846068B2 (en) | 2008-04-18 | 2014-09-30 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising a local anesthetic |
US8372060B2 (en) * | 2008-05-13 | 2013-02-12 | Kci Licensing, Inc. | Catheter/filament style device and methods for treatment of wounds beneath the surface of the skin |
US8557271B2 (en) * | 2008-07-16 | 2013-10-15 | Warsaw Orthopedic, Inc. | Drug depot implantable within a joint |
US20100015049A1 (en) * | 2008-07-16 | 2010-01-21 | Warsaw Orthopedic, Inc. | Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
US9492375B2 (en) | 2008-07-23 | 2016-11-15 | Warsaw Orthopedic, Inc. | Foam carrier for bone grafting |
WO2010028070A1 (en) * | 2008-09-02 | 2010-03-11 | Life Spine, Inc. | Peek spinal mesh and peek spinal mesh applicator |
EP2339985A4 (en) * | 2008-09-12 | 2013-07-03 | Articulinx Inc | Tether-based orthopedic joint device delivery methods |
US9623222B2 (en) * | 2008-10-30 | 2017-04-18 | Warsaw Orthopedic, Inc. | Drug depot with anchor |
US8980317B2 (en) | 2008-12-23 | 2015-03-17 | Warsaw Orthopedic, Inc. | Methods and compositions for treating infections comprising a local anesthetic |
US20100228097A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Methods and compositions to diagnose pain |
US20100226959A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Matrix that prolongs growth factor release |
US20100239632A1 (en) | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
US8617583B2 (en) | 2009-07-17 | 2013-12-31 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis |
US8653029B2 (en) | 2009-07-30 | 2014-02-18 | Warsaw Orthopedic, Inc. | Flowable paste and putty bone void filler |
US8231891B2 (en) | 2009-07-31 | 2012-07-31 | Warsaw Orthopedic, Inc. | Implantable drug depot for weight control |
US20110097375A1 (en) | 2009-10-26 | 2011-04-28 | Warsaw Orthopedic, Inc. | Formulation for preventing or reducing bleeding at a surgical site |
US8597192B2 (en) | 2009-10-30 | 2013-12-03 | Warsaw Orthopedic, Inc. | Ultrasonic devices and methods to diagnose pain generators |
US8764806B2 (en) | 2009-12-07 | 2014-07-01 | Samy Abdou | Devices and methods for minimally invasive spinal stabilization and instrumentation |
US8758791B2 (en) * | 2010-01-26 | 2014-06-24 | Warsaw Orthopedic, Inc. | Highly compression resistant matrix with porous skeleton |
US8475824B2 (en) * | 2010-01-26 | 2013-07-02 | Warsaw Orthopedic, Inc. | Resorbable matrix having elongated particles |
US9125902B2 (en) * | 2010-01-28 | 2015-09-08 | Warsaw Orthopedic, Inc. | Methods for treating an intervertebral disc using local analgesics |
US9486500B2 (en) | 2010-01-28 | 2016-11-08 | Warsaw Orthopedic, Inc. | Osteoimplant and methods for making |
US20110184284A1 (en) * | 2010-01-28 | 2011-07-28 | Warsaw Orthopedic, Inc. | Non-invasive devices and methods to diagnose pain generators |
US9050274B2 (en) * | 2010-01-28 | 2015-06-09 | Warsaw Orthopedic, Inc. | Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents |
BR112012029391A2 (en) * | 2010-05-19 | 2017-07-11 | Transmed7 Llc | methods and apparatus for in situ training of surgical implants |
US8449490B2 (en) * | 2010-09-11 | 2013-05-28 | Aleeva Medical Inc. | Disc shunt delivery with stepped needle |
US8740982B2 (en) | 2010-10-26 | 2014-06-03 | Kyphon Sarl | Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis |
US8404268B2 (en) | 2010-10-26 | 2013-03-26 | Kyphon Sarl | Locally targeted anti-fibrotic agents and methods of use |
US9414930B2 (en) | 2010-10-26 | 2016-08-16 | Kyphon SÀRL | Activatable devices containing a chemonucleolysis agent |
US8613938B2 (en) | 2010-11-15 | 2013-12-24 | Zimmer Orthobiologics, Inc. | Bone void fillers |
WO2012075451A2 (en) | 2010-12-03 | 2012-06-07 | Warsaw Orthopedic, Inc. | Clonidine and gaba compounds in a biodegradable polymer carrier |
WO2012075447A2 (en) | 2010-12-03 | 2012-06-07 | Warsaw Orthopedic, Inc. | Compositions and methods for delivering clonidine and bupivacaine to a target tissue site |
US9060978B2 (en) | 2011-01-24 | 2015-06-23 | Warsaw Orthopedic, Inc. | Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist |
US9717779B2 (en) | 2011-01-31 | 2017-08-01 | Warsaw Orthopedic, Inc. | Implantable matrix having optimum ligand concentrations |
US9511077B2 (en) | 2011-04-25 | 2016-12-06 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an anabolic agent for wound healing |
US9592243B2 (en) | 2011-04-25 | 2017-03-14 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an anabolic agent for treatment of an injury |
US8845728B1 (en) | 2011-09-23 | 2014-09-30 | Samy Abdou | Spinal fixation devices and methods of use |
US8758806B2 (en) | 2012-01-23 | 2014-06-24 | Warsaw Orthopedic, Inc. | Human lubrication gel |
US20130226240A1 (en) | 2012-02-22 | 2013-08-29 | Samy Abdou | Spinous process fixation devices and methods of use |
US9511018B2 (en) | 2012-04-05 | 2016-12-06 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable matrix |
US8993978B2 (en) | 2012-05-04 | 2015-03-31 | Honeywell International Inc. | Method for assessing an alpha particle emission potential of A metallic material |
CN104582639A (en) | 2012-05-29 | 2015-04-29 | Nlt-脊椎有限公司 | Laterally deflectable implant |
US9198767B2 (en) | 2012-08-28 | 2015-12-01 | Samy Abdou | Devices and methods for spinal stabilization and instrumentation |
US9320617B2 (en) | 2012-10-22 | 2016-04-26 | Cogent Spine, LLC | Devices and methods for spinal stabilization and instrumentation |
US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
US10070969B2 (en) | 2013-01-17 | 2018-09-11 | Stryker European Holdings I, Llc | Annulus plug for intervertebral disc repair |
CN104068924B (en) * | 2014-01-20 | 2016-03-30 | 首都医科大学附属北京朝阳医院 | The knee joint cavity implantation device of Zhi Liao popliteal cyst |
US9764122B2 (en) | 2014-07-25 | 2017-09-19 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having an occluding member |
US9775978B2 (en) | 2014-07-25 | 2017-10-03 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
CA2977625A1 (en) | 2014-12-29 | 2016-07-07 | Bioventus, Llc | Systems and methods for improved delivery of osteoinductive molecules in bone repair |
US10857003B1 (en) | 2015-10-14 | 2020-12-08 | Samy Abdou | Devices and methods for vertebral stabilization |
US10076650B2 (en) | 2015-11-23 | 2018-09-18 | Warsaw Orthopedic, Inc. | Enhanced stylet for drug depot injector |
USD802755S1 (en) | 2016-06-23 | 2017-11-14 | Warsaw Orthopedic, Inc. | Drug pellet cartridge |
US10973648B1 (en) | 2016-10-25 | 2021-04-13 | Samy Abdou | Devices and methods for vertebral bone realignment |
US10744000B1 (en) | 2016-10-25 | 2020-08-18 | Samy Abdou | Devices and methods for vertebral bone realignment |
US10434261B2 (en) | 2016-11-08 | 2019-10-08 | Warsaw Orthopedic, Inc. | Drug pellet delivery system and method |
GB201708909D0 (en) * | 2017-06-05 | 2017-07-19 | Orthox Ltd | Implantable tissue repair devices and methods for manufacturing the same |
US11179248B2 (en) | 2018-10-02 | 2021-11-23 | Samy Abdou | Devices and methods for spinal implantation |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4294753A (en) | 1980-08-04 | 1981-10-13 | The Regents Of The University Of California | Bone morphogenetic protein process |
US5106748A (en) | 1986-07-01 | 1992-04-21 | Genetics Institute, Inc. | Dna sequences encoding 5 proteins |
US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
US4877864A (en) | 1987-03-26 | 1989-10-31 | Genetics Institute, Inc. | Osteoinductive factors |
US5187076A (en) | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
US5366875A (en) | 1986-07-01 | 1994-11-22 | Genetics Institute, Inc. | Methods for producing BMP-7 proteins |
US5108438A (en) * | 1989-03-02 | 1992-04-28 | Regen Corporation | Prosthetic intervertebral disc |
US4772287A (en) * | 1987-08-20 | 1988-09-20 | Cedar Surgical, Inc. | Prosthetic disc and method of implanting |
AT393326B (en) | 1988-08-02 | 1991-09-25 | Avl Verbrennungskraft Messtech | INDICATOR SUBSTANCE FOR A MEASURING DEVICE FOR THE OPTICAL DETERMINATION OF INTERESTING PARAMETERS OF A SAMPLE AND MEASURING PROCEDURE THEREFOR |
DE3922203C1 (en) * | 1989-07-06 | 1990-10-25 | Martin Nolde | Surgical instrument for the implantation of an intervertebral disc core prosthesis |
US5192326A (en) * | 1990-12-21 | 1993-03-09 | Pfizer Hospital Products Group, Inc. | Hydrogel bead intervertebral disc nucleus |
US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
ES2127757T3 (en) | 1991-06-25 | 1999-05-01 | Genetics Inst | COMPOSITIONS BMP-9. |
DE4224285C2 (en) | 1992-07-23 | 1995-09-21 | Rolf Goldschmidt | Support structure for supporting flat components |
US5534028A (en) * | 1993-04-20 | 1996-07-09 | Howmedica, Inc. | Hydrogel intervertebral disc nucleus with diminished lateral bulging |
EP1378572B1 (en) | 1993-05-12 | 2006-10-25 | Genetics Institute, LLC | Bmp-11 compositions |
US5522898A (en) * | 1993-09-16 | 1996-06-04 | Howmedica Inc. | Dehydration of hydrogels |
US5514180A (en) * | 1994-01-14 | 1996-05-07 | Heggeness; Michael H. | Prosthetic intervertebral devices |
US5571189A (en) * | 1994-05-20 | 1996-11-05 | Kuslich; Stephen D. | Expandable fabric implant for stabilizing the spinal motion segment |
AU2621295A (en) * | 1994-05-24 | 1995-12-18 | Smith & Nephew Plc | Intervertebral disc implant |
EP0700671B1 (en) * | 1994-09-08 | 2001-08-08 | Stryker Technologies Corporation | Hydrogel intervertebral disc nucleus |
US6048964A (en) * | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
ATE330644T1 (en) | 1995-12-18 | 2006-07-15 | Angiotech Biomaterials Corp | CROSS-LINKED POLYMER MATERIALS AND METHODS FOR USE THEREOF |
US5645597A (en) * | 1995-12-29 | 1997-07-08 | Krapiva; Pavel I. | Disc replacement method and apparatus |
US6054229A (en) * | 1996-07-19 | 2000-04-25 | Ztek Corporation | System for electric generation, heating, cooling, and ventilation |
US5964807A (en) * | 1996-08-08 | 1999-10-12 | Trustees Of The University Of Pennsylvania | Compositions and methods for intervertebral disc reformation |
GB9704749D0 (en) * | 1997-03-07 | 1997-04-23 | Univ London | Tissue Implant |
EP1056413A4 (en) | 1998-02-27 | 2003-08-20 | Bioelastics Res Ltd | Injectable implants for tissue augmentation and restoration |
US6224630B1 (en) * | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
US6132465A (en) * | 1998-06-04 | 2000-10-17 | Raymedica, Inc. | Tapered prosthetic spinal disc nucleus |
US20010055594A1 (en) * | 1998-09-25 | 2001-12-27 | Kjell Olmarker | Use of certain drugs for treating nerve root injury |
SE9803710L (en) * | 1998-09-25 | 2000-03-26 | A & Science Invest Ab | Use of certain substances for the treatment of nerve root damage |
US6958149B2 (en) * | 1998-10-06 | 2005-10-25 | Stryker Corporation | Repair of larynx, trachea, and other fibrocartilaginous tissues |
US20010006948A1 (en) * | 1998-11-25 | 2001-07-05 | James D. Kang | Gene transfer to intervertebral disc cells |
US6419944B2 (en) * | 1999-02-24 | 2002-07-16 | Edward L. Tobinick | Cytokine antagonists for the treatment of localized disorders |
US6428576B1 (en) | 1999-04-16 | 2002-08-06 | Endospine, Ltd. | System for repairing inter-vertebral discs |
US6764514B1 (en) * | 1999-04-26 | 2004-07-20 | Sdgi Holdings, Inc. | Prosthetic apparatus and method |
US6419704B1 (en) * | 1999-10-08 | 2002-07-16 | Bret Ferree | Artificial intervertebral disc replacement methods and apparatus |
SE9902155L (en) | 1999-06-09 | 2000-12-10 | Bjoern Rydevik | Serum antibodies |
US6264695B1 (en) * | 1999-09-30 | 2001-07-24 | Replication Medical, Inc. | Spinal nucleus implant |
US6723335B1 (en) | 2000-04-07 | 2004-04-20 | Jeffrey William Moehlenbruck | Methods and compositions for treating intervertebral disc degeneration |
CA2413353C (en) | 2000-06-29 | 2013-01-29 | Rita Kandel | Intervertebral disc |
-
2000
- 2000-12-06 JP JP2001546319A patent/JP4672947B2/en not_active Expired - Fee Related
- 2000-12-06 ES ES00992392T patent/ES2278648T3/en not_active Expired - Lifetime
- 2000-12-06 DK DK00992392T patent/DK1244388T3/en active
- 2000-12-06 CA CA002392721A patent/CA2392721C/en not_active Expired - Fee Related
- 2000-12-06 WO PCT/US2000/042610 patent/WO2001045577A2/en active IP Right Grant
- 2000-12-06 EP EP00992392A patent/EP1244388B1/en not_active Expired - Lifetime
- 2000-12-06 DE DE60033055T patent/DE60033055D1/en not_active Expired - Lifetime
- 2000-12-06 AU AU43099/01A patent/AU774481B2/en not_active Ceased
-
2002
- 2002-06-06 US US10/165,347 patent/US20020173851A1/en not_active Abandoned
-
2004
- 2004-11-17 US US10/990,823 patent/US7318840B2/en not_active Expired - Lifetime
-
2007
- 2007-04-05 CY CY20071100493T patent/CY1106498T1/en unknown
- 2007-10-23 US US11/877,235 patent/US8349012B2/en not_active Expired - Lifetime
Cited By (181)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9675347B2 (en) | 1999-10-20 | 2017-06-13 | Krt Investors, Inc. | Apparatus for the treatment of tissue |
US8632590B2 (en) * | 1999-10-20 | 2014-01-21 | Anulex Technologies, Inc. | Apparatus and methods for the treatment of the intervertebral disc |
US9114025B2 (en) | 1999-10-20 | 2015-08-25 | Krt Investors, Inc. | Methods and devices for spinal disc annulus reconstruction and repair |
US9095442B2 (en) | 1999-10-20 | 2015-08-04 | Krt Investors, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8556977B2 (en) | 1999-10-20 | 2013-10-15 | Anulex Technologies, Inc. | Tissue anchoring system and method |
US8128698B2 (en) | 1999-10-20 | 2012-03-06 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US7727263B2 (en) | 2000-02-16 | 2010-06-01 | Trans1, Inc. | Articulating spinal implant |
US7744599B2 (en) | 2000-02-16 | 2010-06-29 | Trans1 Inc. | Articulating spinal implant |
US7753941B2 (en) | 2000-04-04 | 2010-07-13 | Anulex Technologies, Inc. | Devices and methods for annular repair of intervertebral discs |
US7905923B2 (en) | 2000-04-04 | 2011-03-15 | Anulex Technologies, Inc. | Devices and methods for annular repair of intervertebral discs |
US7204851B2 (en) * | 2000-08-30 | 2007-04-17 | Sdgi Holdings, Inc. | Method and apparatus for delivering an intervertebral disc implant |
US20040117019A1 (en) * | 2000-08-30 | 2004-06-17 | Trieu Hai H. | Method and apparatus for delivering an intervertebral disc implant |
US7857818B2 (en) * | 2000-08-30 | 2010-12-28 | Warsaw Orthopedic, Inc. | Method and apparatus for delivering an intervertebral disc implant |
US7267687B2 (en) | 2001-10-02 | 2007-09-11 | Rex Medical, L.P | Spinal implant and method of use |
US9095449B2 (en) | 2001-10-02 | 2015-08-04 | Rex Medical, L. P. | Method of inserting a spinal implant |
US8012211B2 (en) * | 2002-11-05 | 2011-09-06 | Spineology, Inc. | Semi-biological intervertebral disc replacement system |
US20120116514A1 (en) * | 2002-11-05 | 2012-05-10 | Kuslich Stephen D | Semi-biological intervertebral disc replacement system |
US11432938B2 (en) | 2003-02-14 | 2022-09-06 | DePuy Synthes Products, Inc. | In-situ intervertebral fusion device and method |
US10555817B2 (en) | 2003-02-14 | 2020-02-11 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US9814590B2 (en) | 2003-02-14 | 2017-11-14 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US9801729B2 (en) | 2003-02-14 | 2017-10-31 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10786361B2 (en) | 2003-02-14 | 2020-09-29 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10433971B2 (en) | 2003-02-14 | 2019-10-08 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10420651B2 (en) | 2003-02-14 | 2019-09-24 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10405986B2 (en) | 2003-02-14 | 2019-09-10 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10376372B2 (en) | 2003-02-14 | 2019-08-13 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US11096794B2 (en) | 2003-02-14 | 2021-08-24 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US11207187B2 (en) | 2003-02-14 | 2021-12-28 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10639164B2 (en) | 2003-02-14 | 2020-05-05 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US9808351B2 (en) | 2003-02-14 | 2017-11-07 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10575959B2 (en) | 2003-02-14 | 2020-03-03 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10492918B2 (en) | 2003-02-14 | 2019-12-03 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10085843B2 (en) | 2003-02-14 | 2018-10-02 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US9925060B2 (en) | 2003-02-14 | 2018-03-27 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US9814589B2 (en) | 2003-02-14 | 2017-11-14 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US9788963B2 (en) | 2003-02-14 | 2017-10-17 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US10583013B2 (en) | 2003-02-14 | 2020-03-10 | DePuy Synthes Products, Inc. | In-situ formed intervertebral fusion device and method |
US7803395B2 (en) | 2003-05-15 | 2010-09-28 | Biomerix Corporation | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
US9061064B2 (en) | 2003-08-06 | 2015-06-23 | Warsaw Orthopedic, Inc. | Implantable devices for chemonucleolysis of intervertebral discs |
US20070003598A1 (en) * | 2003-08-06 | 2007-01-04 | Warsaw Orthopedic, Inc. | Osteogenic implants for soft tissue |
US8920828B2 (en) | 2003-08-06 | 2014-12-30 | Warsaw Orthopedic, Inc. | Implants for treatment of symptomatic or degenerated intervertebral discs |
US20070122446A1 (en) * | 2003-08-06 | 2007-05-31 | Trieu Hai H | Implants for treatment of symptomatic or degenerated intervertebral discs |
US20070128575A1 (en) * | 2003-08-06 | 2007-06-07 | Trieu Hai H | Implantable devices for chemonucleolysis of intervertebral discs |
US7799033B2 (en) | 2003-10-23 | 2010-09-21 | Trans1 Inc. | Access kits for enabling axial access and procedures in the spine |
US7763025B2 (en) | 2003-10-23 | 2010-07-27 | Trans1 Inc. | Spinal fusion kit for guiding instrumentation through soft tissue to a point on the spine |
US7914535B2 (en) | 2003-10-23 | 2011-03-29 | Trans1 Inc. | Method and apparatus for manipulating material in the spine |
US7740633B2 (en) | 2003-10-23 | 2010-06-22 | Trans1 Inc. | Guide pin for guiding instrumentation along a soft tissue tract to a point on the spine |
US7799032B2 (en) | 2003-10-23 | 2010-09-21 | Trans1 Inc. | Guide pin introducer for guiding instrumentation through soft tissue to a point on the spine |
US8052613B2 (en) | 2003-10-23 | 2011-11-08 | Trans1 Inc. | Spinal nucleus extraction tool |
US20050149046A1 (en) * | 2003-12-24 | 2005-07-07 | Friedman Craig D. | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
US8029511B2 (en) | 2004-03-22 | 2011-10-04 | Disc Dynamics, Inc. | Multi-stage biomaterial injection system for spinal implants |
US20050209601A1 (en) * | 2004-03-22 | 2005-09-22 | Disc Dynamics, Inc. | Multi-stage biomaterial injection system for spinal implants |
US20050209602A1 (en) * | 2004-03-22 | 2005-09-22 | Disc Dynamics, Inc. | Multi-stage biomaterial injection system for spinal implants |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
US20070270844A1 (en) * | 2004-11-03 | 2007-11-22 | The Regents Of The University Of Michigan | Biodegradable implant for intertransverse process fusion |
US9724205B2 (en) * | 2004-11-03 | 2017-08-08 | The Regents Of The University Of Michigan | Biodegradable implant for intertransverse process fusion |
US7806934B2 (en) * | 2004-12-16 | 2010-10-05 | Replication Medical Inc. | Radially compressed dehydrated spinal nucleus implants |
US20060136065A1 (en) * | 2004-12-16 | 2006-06-22 | Replication Medical Inc. | Radially compressed dehydrated spinal nucleus implants |
US8070818B2 (en) | 2005-04-29 | 2011-12-06 | Jmea Corporation | Disc annulus repair system |
US8177847B2 (en) | 2005-04-29 | 2012-05-15 | Jmea Corporation | Disc repair system |
US8961530B2 (en) | 2005-04-29 | 2015-02-24 | Jmea Corporation | Implantation system for tissue repair |
US8317868B2 (en) | 2005-04-29 | 2012-11-27 | Jmea Corporation | Disc repair system |
US8702718B2 (en) | 2005-04-29 | 2014-04-22 | Jmea Corporation | Implantation system for tissue repair |
US8162992B2 (en) * | 2005-04-30 | 2012-04-24 | Warsaw Orthopedic, Inc. | Spinal fusion with osteogenic material and migration barrier |
US20060247783A1 (en) * | 2005-04-30 | 2006-11-02 | Mckay William F | Spinal fusion with osteogenic material and migration barrier |
US20090082719A1 (en) * | 2005-05-03 | 2009-03-26 | Yeung Jeffrey E | Injection device for the intervertebral disc |
US7938818B2 (en) * | 2005-05-03 | 2011-05-10 | Yeung Jeffrey E | Alleviate back pain by increasing pH of the disc |
US20110213402A1 (en) * | 2005-05-24 | 2011-09-01 | Kyphon Sarl | Low-compliance expandable medical device |
US7988735B2 (en) * | 2005-06-15 | 2011-08-02 | Matthew Yurek | Mechanical apparatus and method for delivering materials into the inter-vertebral body space for nucleus replacement |
US8092548B2 (en) | 2005-06-22 | 2012-01-10 | Warsaw Orthopedic, Inc. | Osteograft treatment to promote osteoinduction and osteograft incorporation |
US7967864B2 (en) | 2005-08-16 | 2011-06-28 | Benvenue Medical, Inc. | Spinal tissue distraction devices |
US9066808B2 (en) | 2005-08-16 | 2015-06-30 | Benvenue Medical, Inc. | Method of interdigitating flowable material with bone tissue |
US8556978B2 (en) | 2005-08-16 | 2013-10-15 | Benvenue Medical, Inc. | Devices and methods for treating the vertebral body |
US10028840B2 (en) | 2005-08-16 | 2018-07-24 | Izi Medical Products, Llc | Spinal tissue distraction devices |
US8591583B2 (en) | 2005-08-16 | 2013-11-26 | Benvenue Medical, Inc. | Devices for treating the spine |
US7785368B2 (en) | 2005-08-16 | 2010-08-31 | Benvenue Medical, Inc. | Spinal tissue distraction devices |
US7670374B2 (en) | 2005-08-16 | 2010-03-02 | Benvenue Medical, Inc. | Methods of distracting tissue layers of the human spine |
US7670375B2 (en) | 2005-08-16 | 2010-03-02 | Benvenue Medical, Inc. | Methods for limiting the movement of material introduced between layers of spinal tissue |
US7955391B2 (en) | 2005-08-16 | 2011-06-07 | Benvenue Medical, Inc. | Methods for limiting the movement of material introduced between layers of spinal tissue |
US7666226B2 (en) | 2005-08-16 | 2010-02-23 | Benvenue Medical, Inc. | Spinal tissue distraction devices |
US7963993B2 (en) | 2005-08-16 | 2011-06-21 | Benvenue Medical, Inc. | Methods of distracting tissue layers of the human spine |
US8454617B2 (en) | 2005-08-16 | 2013-06-04 | Benvenue Medical, Inc. | Devices for treating the spine |
US8801787B2 (en) | 2005-08-16 | 2014-08-12 | Benvenue Medical, Inc. | Methods of distracting tissue layers of the human spine |
US8808376B2 (en) | 2005-08-16 | 2014-08-19 | Benvenue Medical, Inc. | Intravertebral implants |
US7666227B2 (en) | 2005-08-16 | 2010-02-23 | Benvenue Medical, Inc. | Devices for limiting the movement of material introduced between layers of spinal tissue |
US7967865B2 (en) | 2005-08-16 | 2011-06-28 | Benvenue Medical, Inc. | Devices for limiting the movement of material introduced between layers of spinal tissue |
US8882836B2 (en) | 2005-08-16 | 2014-11-11 | Benvenue Medical, Inc. | Apparatus and method for treating bone |
US8366773B2 (en) | 2005-08-16 | 2013-02-05 | Benvenue Medical, Inc. | Apparatus and method for treating bone |
US9788974B2 (en) | 2005-08-16 | 2017-10-17 | Benvenue Medical, Inc. | Spinal tissue distraction devices |
US8961609B2 (en) | 2005-08-16 | 2015-02-24 | Benvenue Medical, Inc. | Devices for distracting tissue layers of the human spine |
US9326866B2 (en) | 2005-08-16 | 2016-05-03 | Benvenue Medical, Inc. | Devices for treating the spine |
US9259326B2 (en) | 2005-08-16 | 2016-02-16 | Benvenue Medical, Inc. | Spinal tissue distraction devices |
US8979929B2 (en) | 2005-08-16 | 2015-03-17 | Benvenue Medical, Inc. | Spinal tissue distraction devices |
US8057544B2 (en) | 2005-08-16 | 2011-11-15 | Benvenue Medical, Inc. | Methods of distracting tissue layers of the human spine |
US9044338B2 (en) | 2005-08-16 | 2015-06-02 | Benvenue Medical, Inc. | Spinal tissue distraction devices |
US7988695B2 (en) | 2005-12-21 | 2011-08-02 | Theken Spine, Llc | Articulated delivery instrument |
WO2007100591A3 (en) * | 2006-02-22 | 2008-01-31 | Ouroboros Inc | Mechanical apparatus and method for artificial disc replacement |
US7976549B2 (en) | 2006-03-23 | 2011-07-12 | Theken Spine, Llc | Instruments for delivering spinal implants |
US8642060B2 (en) | 2006-04-24 | 2014-02-04 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for osteal growth |
US7879027B2 (en) | 2006-04-24 | 2011-02-01 | Warsaw Orthopedic, Inc. | Controlled release devices for fusion of osteal structures |
US20070276337A1 (en) * | 2006-04-24 | 2007-11-29 | Warsaw Orthopedic, Inc. | Controlled release devices for fusion of osteal structures |
US20070250044A1 (en) * | 2006-04-24 | 2007-10-25 | Sdgi Holdings, Inc. | Controlled release systems and methods for intervertebral discs |
US8642059B2 (en) | 2006-04-24 | 2014-02-04 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for intervertebral discs |
US20070250045A1 (en) * | 2006-04-24 | 2007-10-25 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for osteal growth |
US20070250046A1 (en) * | 2006-04-24 | 2007-10-25 | Sdgi Holdings, Inc. | Controlled release devices for therapeutic treatments of spinal discs |
US7771414B2 (en) | 2006-04-24 | 2010-08-10 | Warsaw Orthopedic, Inc. | Controlled release devices for therapeutic treatments of spinal discs |
US8506636B2 (en) | 2006-09-08 | 2013-08-13 | Theken Spine, Llc | Offset radius lordosis |
US20080065218A1 (en) * | 2006-09-13 | 2008-03-13 | O'neil Michael J | Annulus fibrosus repair devices and techniques |
US20080172126A1 (en) * | 2006-10-03 | 2008-07-17 | Reynolds Martin A | Nucleus pulposus injection devices and methods |
US9259324B2 (en) * | 2006-11-16 | 2016-02-16 | Rex Medical, L.P. | Spinal implant and method of use |
US8920506B2 (en) | 2006-11-16 | 2014-12-30 | Rex Medical, L.P. | Spinal implant and method of use |
US20080133012A1 (en) * | 2006-11-16 | 2008-06-05 | Mcguckin James F | Spinal implant and method of use |
US8287599B2 (en) | 2006-11-16 | 2012-10-16 | Rex Medical, L.P. | Spinal implant and method of use |
US20150094817A1 (en) * | 2006-11-16 | 2015-04-02 | Rex Medical, L.P. | Spinal implant and method of use |
US8142507B2 (en) | 2006-11-16 | 2012-03-27 | Rex Medical, L.P. | Spinal implant and method of use |
US11432942B2 (en) | 2006-12-07 | 2022-09-06 | DePuy Synthes Products, Inc. | Intervertebral implant |
US11497618B2 (en) | 2006-12-07 | 2022-11-15 | DePuy Synthes Products, Inc. | Intervertebral implant |
US11642229B2 (en) | 2006-12-07 | 2023-05-09 | DePuy Synthes Products, Inc. | Intervertebral implant |
US11273050B2 (en) | 2006-12-07 | 2022-03-15 | DePuy Synthes Products, Inc. | Intervertebral implant |
US11660206B2 (en) | 2006-12-07 | 2023-05-30 | DePuy Synthes Products, Inc. | Intervertebral implant |
US11712345B2 (en) | 2006-12-07 | 2023-08-01 | DePuy Synthes Products, Inc. | Intervertebral implant |
US10285821B2 (en) | 2007-02-21 | 2019-05-14 | Benvenue Medical, Inc. | Devices for treating the spine |
US10575963B2 (en) | 2007-02-21 | 2020-03-03 | Benvenue Medical, Inc. | Devices for treating the spine |
US8968408B2 (en) | 2007-02-21 | 2015-03-03 | Benvenue Medical, Inc. | Devices for treating the spine |
US10426629B2 (en) | 2007-02-21 | 2019-10-01 | Benvenue Medical, Inc. | Devices for treating the spine |
US9642712B2 (en) | 2007-02-21 | 2017-05-09 | Benvenue Medical, Inc. | Methods for treating the spine |
US10322166B2 (en) | 2007-02-23 | 2019-06-18 | Kunovus Pty Ltd | Composition and method for the treatment or prevention of spinal disorders |
US8828941B2 (en) | 2007-02-23 | 2014-09-09 | Divya Diwan | Composition and method for the treatment or prevention of spinal disorders |
US20110144718A1 (en) * | 2007-02-23 | 2011-06-16 | Ashish Diwan | Composition and method for the treatment or prevention of spinal disorders |
US9480819B2 (en) | 2007-02-23 | 2016-11-01 | Divya Diwan | Composition and method for the treatment or prevention of spinal disorders |
WO2008101300A1 (en) * | 2007-02-23 | 2008-08-28 | Cellixe Pty Ltd | Composition and method for the treatment or prevention of spinal disorders |
US10973652B2 (en) | 2007-06-26 | 2021-04-13 | DePuy Synthes Products, Inc. | Highly lordosed fusion cage |
US11622868B2 (en) | 2007-06-26 | 2023-04-11 | DePuy Synthes Products, Inc. | Highly lordosed fusion cage |
US11737881B2 (en) | 2008-01-17 | 2023-08-29 | DePuy Synthes Products, Inc. | Expandable intervertebral implant and associated method of manufacturing the same |
US11712342B2 (en) | 2008-04-05 | 2023-08-01 | DePuy Synthes Products, Inc. | Expandable intervertebral implant |
US11701234B2 (en) | 2008-04-05 | 2023-07-18 | DePuy Synthes Products, Inc. | Expandable intervertebral implant |
US11617655B2 (en) | 2008-04-05 | 2023-04-04 | DePuy Synthes Products, Inc. | Expandable intervertebral implant |
US11602438B2 (en) | 2008-04-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Expandable intervertebral implant |
US11707359B2 (en) | 2008-04-05 | 2023-07-25 | DePuy Synthes Products, Inc. | Expandable intervertebral implant |
US11712341B2 (en) | 2008-04-05 | 2023-08-01 | DePuy Synthes Products, Inc. | Expandable intervertebral implant |
US9192372B2 (en) | 2008-10-14 | 2015-11-24 | Krt Investors, Inc. | Method for the treatment of tissue |
US8163022B2 (en) | 2008-10-14 | 2012-04-24 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8454697B2 (en) | 2008-10-14 | 2013-06-04 | Anulex Technologies, Inc. | Method and apparatus for the treatment of tissue |
US8535327B2 (en) | 2009-03-17 | 2013-09-17 | Benvenue Medical, Inc. | Delivery apparatus for use with implantable medical devices |
US11612491B2 (en) | 2009-03-30 | 2023-03-28 | DePuy Synthes Products, Inc. | Zero profile spinal fusion cage |
US8211126B2 (en) | 2009-09-22 | 2012-07-03 | Jmea Corporation | Tissue repair system |
US8603118B2 (en) | 2009-09-22 | 2013-12-10 | Jmea Corporation | Tissue repair system |
US11607321B2 (en) | 2009-12-10 | 2023-03-21 | DePuy Synthes Products, Inc. | Bellows-like expandable interbody fusion cage |
US8652153B2 (en) | 2010-01-11 | 2014-02-18 | Anulex Technologies, Inc. | Intervertebral disc annulus repair system and bone anchor delivery tool |
US9795372B2 (en) | 2010-01-11 | 2017-10-24 | Krt Investors, Inc. | Intervertebral disc annulus repair system and bone anchor delivery tool |
US8460319B2 (en) | 2010-01-11 | 2013-06-11 | Anulex Technologies, Inc. | Intervertebral disc annulus repair system and method |
US11911287B2 (en) | 2010-06-24 | 2024-02-27 | DePuy Synthes Products, Inc. | Lateral spondylolisthesis reduction cage |
US10966840B2 (en) | 2010-06-24 | 2021-04-06 | DePuy Synthes Products, Inc. | Enhanced cage insertion assembly |
US11872139B2 (en) | 2010-06-24 | 2024-01-16 | DePuy Synthes Products, Inc. | Enhanced cage insertion assembly |
US11654033B2 (en) | 2010-06-29 | 2023-05-23 | DePuy Synthes Products, Inc. | Distractible intervertebral implant |
US11452607B2 (en) | 2010-10-11 | 2022-09-27 | DePuy Synthes Products, Inc. | Expandable interspinous process spacer implant |
US8814873B2 (en) | 2011-06-24 | 2014-08-26 | Benvenue Medical, Inc. | Devices and methods for treating bone tissue |
US9314252B2 (en) | 2011-06-24 | 2016-04-19 | Benvenue Medical, Inc. | Devices and methods for treating bone tissue |
US10179012B2 (en) | 2013-01-28 | 2019-01-15 | Cartiva, Inc. | Systems and methods for orthopedic repair |
US11471199B2 (en) | 2013-01-28 | 2022-10-18 | Cartiva, Inc. | Systems and methods for orthopedic repair |
US9737294B2 (en) | 2013-01-28 | 2017-08-22 | Cartiva, Inc. | Method and system for orthopedic repair |
US11497619B2 (en) | 2013-03-07 | 2022-11-15 | DePuy Synthes Products, Inc. | Intervertebral implant |
US11850164B2 (en) | 2013-03-07 | 2023-12-26 | DePuy Synthes Products, Inc. | Intervertebral implant |
US10085783B2 (en) | 2013-03-14 | 2018-10-02 | Izi Medical Products, Llc | Devices and methods for treating bone tissue |
US9913728B2 (en) | 2013-03-14 | 2018-03-13 | Quandary Medical, Llc | Spinal implants and implantation system |
US9814598B2 (en) | 2013-03-14 | 2017-11-14 | Quandary Medical, Llc | Spinal implants and implantation system |
US11426290B2 (en) | 2015-03-06 | 2022-08-30 | DePuy Synthes Products, Inc. | Expandable intervertebral implant, system, kit and method |
US11596523B2 (en) | 2016-06-28 | 2023-03-07 | Eit Emerging Implant Technologies Gmbh | Expandable and angularly adjustable articulating intervertebral cages |
US11596522B2 (en) | 2016-06-28 | 2023-03-07 | Eit Emerging Implant Technologies Gmbh | Expandable and angularly adjustable intervertebral cages with articulating joint |
US11510788B2 (en) | 2016-06-28 | 2022-11-29 | Eit Emerging Implant Technologies Gmbh | Expandable, angularly adjustable intervertebral cages |
US10888433B2 (en) | 2016-12-14 | 2021-01-12 | DePuy Synthes Products, Inc. | Intervertebral implant inserter and related methods |
US11213402B2 (en) | 2017-01-11 | 2022-01-04 | Loubert S. Suddaby | Endoscopically implantable inflatable interbody fusion device |
US11446155B2 (en) | 2017-05-08 | 2022-09-20 | Medos International Sarl | Expandable cage |
US11344424B2 (en) | 2017-06-14 | 2022-05-31 | Medos International Sarl | Expandable intervertebral implant and related methods |
US10940016B2 (en) | 2017-07-05 | 2021-03-09 | Medos International Sarl | Expandable intervertebral fusion cage |
US11446156B2 (en) | 2018-10-25 | 2022-09-20 | Medos International Sarl | Expandable intervertebral implant, inserter instrument, and related methods |
US11426286B2 (en) | 2020-03-06 | 2022-08-30 | Eit Emerging Implant Technologies Gmbh | Expandable intervertebral implant |
US11806245B2 (en) | 2020-03-06 | 2023-11-07 | Eit Emerging Implant Technologies Gmbh | Expandable intervertebral implant |
US11850160B2 (en) | 2021-03-26 | 2023-12-26 | Medos International Sarl | Expandable lordotic intervertebral fusion cage |
US11752009B2 (en) | 2021-04-06 | 2023-09-12 | Medos International Sarl | Expandable intervertebral fusion cage |
Also Published As
Publication number | Publication date |
---|---|
JP4672947B2 (en) | 2011-04-20 |
CA2392721A1 (en) | 2001-06-28 |
US7318840B2 (en) | 2008-01-15 |
EP1244388B1 (en) | 2007-01-17 |
ES2278648T3 (en) | 2007-08-16 |
WO2001045577A3 (en) | 2002-07-11 |
WO2001045577A9 (en) | 2002-12-05 |
AU774481B2 (en) | 2004-07-01 |
AU4309901A (en) | 2001-07-03 |
DK1244388T3 (en) | 2007-05-14 |
EP1244388A2 (en) | 2002-10-02 |
US8349012B2 (en) | 2013-01-08 |
US20060004456A1 (en) | 2006-01-05 |
CA2392721C (en) | 2009-01-20 |
DE60033055D1 (en) | 2007-03-08 |
WO2001045577A2 (en) | 2001-06-28 |
CY1106498T1 (en) | 2012-01-25 |
US20080114458A1 (en) | 2008-05-15 |
JP2003518021A (en) | 2003-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7318840B2 (en) | Intervertebral disc treatment devices and methods | |
US7563282B2 (en) | Method of supporting nucleus pulposus | |
US7998213B2 (en) | Intervertebral disc herniation repair | |
US7553329B2 (en) | Stabilized intervertebral disc barrier | |
US8157863B2 (en) | Devices, apparatus, and methods for bilateral approach to disc augmentation | |
US20090222096A1 (en) | Multi-compartment expandable devices and methods for intervertebral disc expansion and augmentation | |
US20120316648A1 (en) | Intervertebral disc reinforcement systems | |
EP0353936A1 (en) | Prosthetic disc containing therapeutic material | |
US20070255286A1 (en) | Devices, apparatus, and methods for improved disc augmentation | |
EP1686929A2 (en) | Stabilized intervertebral disc barrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SDGI HOLDINGS, INC., DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MCKAY, WILLIAM F.;REEL/FRAME:013129/0205 Effective date: 20020617 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: WARSAW ORTHOPEDIC, INC.,INDIANA Free format text: MERGER;ASSIGNOR:SDGI HOLDINGS, INC.;REEL/FRAME:018573/0086 Effective date: 20061201 Owner name: WARSAW ORTHOPEDIC, INC., INDIANA Free format text: MERGER;ASSIGNOR:SDGI HOLDINGS, INC.;REEL/FRAME:018573/0086 Effective date: 20061201 |
|
AS | Assignment |
Owner name: WARSAW ORTHOPEDIC, INC, INDIANA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT T0 REMOVE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 018573 FRAME: 0086. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER;ASSIGNOR:SDGI HOLDINGS, INC.;REEL/FRAME:033904/0891 Effective date: 20061201 |